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Abstract 
Helicobacter pylori (Hp) colonizes the human gastric and duodenal mucosa and the infection may 
cause peptic ulcers and gastric adenocarcinoma. Half of the world’s population is infected with 
Hp with the highest prevalence in developing countries. Hp infection is normally acquired during 
childhood, but comparatively little is known about immune responses to acute infection or 
potential differences in responses between individuals in Hp endemic and nonendemic countries. 
The overall aim of this thesis was to analyze humoral and cellular immune responses to Hp in 
children and adults living in a country with a high prevalence of Hp infections, i.e. Bangladesh. 
 T- and B-cell responses to Hp were analyzed in Hp infected adults from Bangladesh and 
Sweden. Comparable numbers of CD19+ B cells and CD4+ T cells and similar levels of Hp-
specific IgA antibodies were found in gastric mucosa from Bangladeshi and Swedish subjects. 
However, higher numbers of CD19+ B cells and higher levels of specific and total IgA antibodies 
were found in the duodenum of the Bangladeshis, possibly due to frequent enteric infections 
causing recruitment of Hp-specific and unspecific lymphocytes to this site. Furthermore, 
Bangladeshi subjects had about two-fold lower Hp-specific IgA and IgG serum antibody titers. 
 To determine the incidence of Hp infection during early childhood in a high endemic area 
and possible associations between infection and different host and environmental factors, a birth 
cohort (BC) study was undertaken in Bangladeshi children from birth up to 24 months. Using 
diagnostic methods suitable for use in less well-equipped laboratories, i.e. stool antigen test and 
serology, 50-60% of the children were found to be positive for Hp at 24 months. Most children 
were initially infected with Hp during spring or autumn and blood group A children had increased 
susceptibility to the infection. Serum and stool samples collected every third month from the BC 
children were analyzed for development of systemic and mucosal antibody responses to acute Hp 
infection. Almost all children mounted specific, ≥4-fold serum IgA and stool IgA responses 
following infection. Serum IgG levels at birth were comparable to the maternal antibody levels 
and decreased during the initial 6 months, whereafter they increased in response to infection. An 
association between spontaneous eradication of Hp infection (in approximately 10% of the 
children) and increased serum antibody responses was found. Pre-existing maternal IgG and 
breast milk IgA antibody levels were associated with delayed onset of Hp infection.  
 To analyze if certain T-cell responses (Th1 and Th17) may contribute to the immune 
responses against Hp, peripheral blood mononuclear cells were isolated and stimulated with Hp 
antigens. Cells from both Bangladeshi infants and adults responded with production of both IL-17 
and IFN-γ, with higher IL-17 responses in infants. These results suggest that Th17 as well as Th1 
type T-cell responses may be important for initial immune responses to Hp in young children. 
 These studies give important information regarding acquisition of Hp during early 
childhood in a high endemic country and provide clues about immune responses that may be 
related to protection against Hp infection.  
 
Keywords: Helicobacter pylori, adults, children, birth cohort, maternal antibodies, serology, 
Th17, T cell, B cell, developing country. 
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ABBREVIATIONS 
 
APC   antigen presenting cell 
AS   asymptomatic 
ASC   antibody secreting cells 
BabA   blood group binding adhesin A  
cagPAI  cytotoxin associated gene pathogenicity island 
CBA   cytokine bead array  
CI   continuously infected 
DU   duodenal ulcer 
ELISA   enzyme-linked immunosorbent assay 
ETEC   enterotoxigenic Escherichia coli 
FCM   flow cytometry 
ICDDR,B  International Centre for Diarrhoeal Disease Research, Bangladesh 
IFN-γ   interferon gamma 
IHC   immunohistochemistry 
IL   interleukin 
IP-10   IFN-γ inducible protein-10 
iTregs   induced regulatory T cells 
LMIC   low and middle-income countries 
LPL   lamina propria lymphocyte 
LPS   lipopolysaccharide 
MALT   mucosa associated lymphoid tissue 
MIG   monokine induced by γ-interferon 
MP   membrane preparation of H. pylori 
PBMC   peripheral blood mononuclear cells 
PCR   polymerase chain reaction 
PHA   phytohemagglutinin 
RI   reinfected 
SabA   sialic acid binding adhesin A 
SE   spontaneously eradicated 
SUH   Sahlgrenska University Hospital 
TGF-β   transforming growth factor-β 
Th   T helper 
TNF-α   tumor necrosis factor-α 
Tregs   regulatory T cells 
UBT   urea breath test 
VacA   vacuolating cytotoxin A 
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INTRODUCTION 
 
History of Helicobacter pylori infection 
For a long time, the human stomach was considered to be a sterile organ, where no 
microorganisms can survive due to the acidic conditions. However, in 1982 Warren and 
Marshall were able to culture Helicobacter pylori bacteria from patients undergoing 
gastroscopy and found that the bacteria were present in patients with active chronic 
gastritis and peptic ulcers (90). Warren and Marshall were recently awarded the Nobel 
Prize (in 2005) for their discovery of H. pylori and its role in gastritis and peptic ulcer 
disease. Today, H. pylori is also recognized as an important cause of gastric cancer and 
mucosa associated lymphoid tissue (MALT) lymphoma (124). 
 
Prevalence of H. pylori 
More than 50 percent of the population worldwide is infected with H. pylori with a higher 
prevalence in developing countries and in groups with poor socio-economic and hygienic 
status than in developed areas (Figure 1). The infection is generally acquired during 
childhood (40, 94).  
 
 
 
 
 
 
 
 
 
 
Figure 1. Prevalence of H. pylori infection in adults in different parts of the world. Prevalence 
data cited in text or adapted from (97, 119, 152). 
  
 The prevalence of H. pylori in adults and children in low and middle-income 
countries (LMIC) and in the industrialized world varies a lot. In Africa (e.g. Ethiopia, 
Gambia and Nigeria), >90% of the adult populations are infected with H. pylori (59, 81, 
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139) and in Gambia, 95% of the children (<5 years) were found to be positive for H. 
pylori (139). In Latin America, e.g. Chile and Mexico, around 70% of the adults were 
shown to be infected with H. pylori and among Mexican children (<5 years), the H. 
pylori prevalence was 47% (106, 147). A high prevalence of H. pylori has also been 
observed in India both in adults (88%) (51) and children less than 5 years (57%) (100). It 
has previously been shown in Bangladesh that the prevalence of H. pylori was 42% 
already by 2 years of age with a rapid increase to 67% by 10 years of age (25, 117) and 
that as many as 84% of 6-9 years old children were H. pylori positive in areas where 
sanitary conditions were very poor (88). Very recently, the prevalence of H. pylori was 
also reported to be relatively high (50%) in Muping city in China (153). On the other 
hand, in industrialized countries like Sweden, only 2% of the children (10-12 years) with 
Scandinavian parents (140) and 11% of the adults (25-50 years) have been reported to be 
infected with H. pylori (136). Slightly higher prevalence has been observed in other 
Western countries such as Italy (43%) and the US (20%) (121), but it is clear that the 
incidence of H. pylori infection in developed countries is relatively low, particularly in 
children, with a higher prevalence in elderly people. As the socioeconomic status has 
improved in developed countries, the prevalence of H. pylori in younger generations has 
declined (42). The age related apparent increase in the prevalence (higher in the older 
generation and lower in younger generation) in developed countries could best be 
explained as a “birth cohort effect.” However, no such effect has been noted in the 
developing world (42, 73). 
 
Transmission of H. pylori infection 
H. pylori is spread within the family and close communities (70) through the immediate 
environment or via environmental reservoirs or vectors. However, little is known about 
the main route of dissemination from an infected individual. The fecal-oral route has been 
suggested in most studies, although oral-oral (34, 137) or gastro-oral routes (79, 109) 
have been proposed by others. In addition, there are reports that H. pylori may be spread 
during episodes of vomiting and diarrhea (76). Recently, we have shown that vomitus 
would be the most likely source of H. pylori in person-to-person transmission whereas 
spread via contaminated water is less likely (66).  
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H. pylori associated diseases 
Most H. pylori infected individuals develop chronic active gastritis. Despite this gastritis, 
most infected individuals remain asymptomatic. In general, the bacterium causes gastric 
or duodenal ulcers in approximately 10-15% of those infected and gastric cancer in 
another 1-2% (39). In fact, the World Health Organization (WHO) designated H. pylori 
as a class 1 carcinogen in 1994. Individuals who have severe gastric atrophy, corpus-
predominant gastritis, or intestinal metaplasia have been reported to have an increased 
risk for development of gastric cancer. In contrast, persons who have antrum-
predominant gastritis and gastric metaplasia in the duodenum have been reported to have 
an increased risk of developing duodenal ulcers. H. pylori infected persons with nonulcer 
dyspepsia, gastric ulcers, or gastric hyperplastic polyps may also have increased risk of 
developing cancer, whereas those with duodenal ulcers do not (143).  
 The prevalence of H. pylori associated diseases seems to vary considerably in 
different parts of the world. These differences have led to coining of the terms “the 
African and Indian enigmas” (52). The African enigma refers to the apparent low 
prevalence of peptic ulcers and gastric cancer in Africa, despite a very high prevalence of 
H. pylori infection. Similarly, the Indian enigma refers to the observation that there are 
areas in Asia where H. pylori infection is very common, such as India, Thailand, 
Bangladesh and Pakistan, but where gastric cancer is rare, whereas in other areas of Asia 
where H. pylori is almost equally prevalent, gastric cancer is frequent (e.g. China, Japan 
and Korea) (52). However, recent analyses of endoscopic data suggest that the enigmas 
are medical myths, as the prevalence of gastric cancer is not unusually or unexpectedly 
low in these parts of the world, but is rather a consequence of the antral predominant 
gastritis commonly found here (52). Furthermore, short life expectancies, inadequate 
health care systems and lack of systemic surveillance and databases are factors that are 
likely to affect the official statistics of H. pylori associated diseases in these areas of the 
world. The reasons for the different patterns of gastritis in different populations are 
however still unclear, but diet, environmental, host and microbial factors have been 
suggested (52). These factors are also likely to influence whether infected individuals 
will remain asymptomatic or develop disease, but the relative contribution of the 
individual factors for the risk of disease development remains to be determined. 
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Treatment of H. pylori infection 
There is no single antibiotic that can be used alone for treatment of H. pylori infection. 
The current treatment consists of a combination therapy with two different antibiotics 
(e.g. metronidazole and amoxicillin) together with a proton-pump inhibitor, which in 
most cases results in successful eradication of the bacteria and healing of ulcers (150). 
However, there are some major drawbacks with such a therapy, including high cost, poor 
patient compliance and increased risk of developing antibiotic resistance, making it 
unsuitable for use e.g. in the developing world. Furthermore, such treatment does not 
protect against reinfections, which frequently occur in areas with high prevalence of H. 
pylori (78, 87). In Bangladesh, the prevalence of metronidazole resistance is high (77%), 
which might be due to frequent use of metronidazole for other intestinal as well as 
gynecological problems (98). Among the H. pylori strains isolated in Bangladesh 15% 
were also tetracycline-resistant (98). In Sweden, on the other hand, resistance to these 
antibiotics was lower with 16% of the strains being resistant to metronidazole and 0.3% 
to tetracycline, most probably due to a restrictive prescription policy (130).  
 
Prevention of H. pylori infection 
Many therapeutic and prophylactic vaccine candidates against H. pylori have been 
evaluated in experimental animals and several of these studies have suggested that it is 
possible to induce protective immunity by vaccination (38, 104, 116, 134). The main 
candidates so far are the virulence factors of H. pylori discussed below, alone or in 
different combinations with various adjuvants (134). Whole bacterial cells and whole cell 
lysates of H. pylori and related Helicobacters have also been frequently tested.  
 A H. pylori vaccine should preferably work at two different levels, e.g. result in a 
decreased risk of developing H. pylori-associated disease for an individual, and to 
decrease the risk of infection at the population level. A prophylactic vaccine should be 
given before an individual becomes infected with H. pylori, e.g. in children, whereas a 
therapeutic vaccine should primarily be given to those who have already developed H. 
pylori associated disease. In addition, because chronic H. pylori infection, even in the 
absence of symptoms, is a risk factor for development of adenocarcinoma (39), 
vaccination of asymptomatic carriers may be justified. Furthermore, a therapeutic vaccine 
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would confer protection against reinfection. However, despite successes in animal 
models, no successful human clinical vaccine trial has been carried out so far (134).  
 
Virulence factors of H. pylori  
H. pylori is a gram-negative bacterium which expresses a variety of different virulence 
factors for survival in the stomach. H. pylori also colonizes areas of gastric metaplasia in 
the duodenum. The virulence factors include the flagellae that provides motility and 
different adhesion factors, e.g. blood group binding adhesin A (BabA) and sialic acid 
binding adhesin A (SabA), which enable H. pylori to adhere to surface mucosal cells and 
to compounds of the mucus layer and thereby avoid bacterial shedding (60, 89). Earlier 
findings have emphasized the importance of the
 
adherence factors for the induction of 
gastric inflammation,
 
ulcer disease, and also gastric adenocarcinoma. It has been found 
that bacterial colonization densities
 
are of great importance for the degree of mucosal 
inflammation
 
and damage, (10, 56, 151) and BabA appears to be a key factor favoring 
high colonization
 
densities. Since presence of the babA2 gene has previously been
 
correlated with both ulcer disease and adenocarcinoma (46), it appears
 
that genetic 
susceptibilities may influence the further development
 
of disease once the bacterial 
colonization is established. 
 CagA is another virulence factor which seems to be associated with more severe 
disease outcome (17). CagA is located within the cytotoxin associated gene pathogenicity 
island (CagPAI, a 40kB segment containing about 30 genes) (73). Many genes in the 
CagPAI encode for a type IV secretion system that can deliver CagA, and possibly other 
proteins, into the mammalian host and thereby affect the function of the epithelial cells. 
Another virulence factor, VacA, induces vacuolation of epithelial cells and can block T-
cell proliferation (27, 44). Both CagA
+
 and VacA
+
 strains are associated with more severe 
disease outcomes. 
 H. pylori also produces large amounts of the enzyme urease, which is localized 
inside and outside the bacterium. Urease breaks down urea (which is normally secreted 
into the stomach) to carbon dioxide and ammonia (which neutralizes gastric acid). The 
survival of H. pylori in the acidic stomach is dependent on urease, and the bacteria would 
eventually die without the enzyme (129). 
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Assays for diagnosis of H. pylori 
Various tests have been developed for the detection of H. pylori infection. The specific 
advantages and disadvantages of these techniques are summarized in table 1. Well 
established methods are histology and bacterial culture from gastric and duodenal 
biopsies, which are arguably considered “gold standards” among the different detection 
methods (35). However, they have relatively low sensitivities and are invasive and labour 
intensive. Furthermore, they require trained pathologists for histological scoring and are 
not suitable for diagnosis in field studies or in young children since these require 
collection of biopsies. In clinical settings, the Urea Breath Test (UBT) is often used as a 
rapid method to detect active infection. In this test, the patient ingests urea labeled with 
either carbon-13 or carbon-14 isotopes and the presence of the labeled isotope is 
measured in exhaled breath carbon dioxide. A positive test indicates that the urea has 
been metabolized by H. pylori urease. Although the UBT usually has a high sensitivity 
for diagnosis of infection, it is limited by being technically cumbersome, time-
consuming, expensive and has low specificity in very young children (<2 years of age) 
(35, 69). Therefore, UBT is not an optimal diagnostic test in field settings or in young 
children.  
  Other noninvasive tests may be more suitable for such studies; e.g. stool antigen 
tests and/or serology. The stool antigen tests, which usually are commercial, are based on 
the detection of H. pylori antigens shed in the stool of infected subjects. Initial reports of 
the monoclonal antibody based enzyme-linked immunosorbent assay (ELISA) test 
(Amplified IDEIA
TM
 Hp StAR
TM
, Dakocytomation, Denmark) were very encouraging, 
showing 100% sensitivity and 91% specificity in adults (47). 
 However, measurement of serological IgG is not suitable alone for detection of H. 
pylori in children although it is relatively simple and can be an immediate option. This is 
because children acquire transplacentally derived IgG from their mothers, which may 
remain for at least 6 months. Furthermore, serology does not reflect active infection, as 
IgG levels remain elevated for a couple of months after eradication of the infection.  
 Finally, a plethora of different polymerase chain reaction (PCR) methods have been 
used to detect H. pylori DNA in clinical specimens. However, the PCR based methods 
are normally primarily used for research and not for diagnostic purposes. 
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Table 1. Diagnostic methods used for detection of H. pylori. 
Bacterial 
detection 
 
Sensitivity 
Specificity 
for 
H. pylori 
Time 
required Live    Dead 
Remarks 
Invasive methods 
Histology  Low High 1-2 days    +         + 
Gold standard, 
inexpensive 
 
Culture Low High 5-7 days    +         - 
Alternate gold 
standard, inexpensive 
 
Rapid urease test 
(CLO) 
Low High <1 day    +         - Rapid, cost-effective  
Noninvasive 
methods 
 
Urea breath test High High <1 day    +         - 
Alternate gold 
standard, not 
appropriate for 
resource poor settings 
or young children, 
relatively expensive 
 
Fecal antigen test Medium High 1 day    -         + 
Simple, sensitivity 
increases with testing 
of multiple samples, 
expensive 
 
Serology Medium High 1-2 days    na       na 
Useful for screening 
and epidemiological 
studies, inexpensive 
 
PCR (biopsy) High High 1 day    +         + 
Relatively simple, 
inexpensive 
 
na; not applicable 
 
Immunology 
Overview of immune responses to H. pylori 
In response to H. pylori infection, the host mounts systemic as well as mucosal immune 
responses with associated gastritis shortly after onset of infection. The mucosal responses 
are characterized by massive infiltration of neutrophils into the gastric mucosa (128) 
which is followed by activation of dendritic cells and recruitment of B and T cells (53, 
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73, 102). During chronic infection, neutrophils remain in the mucosa together with 
lymphocytes, which are scattered throughout the mucosa, but may also form lymphoid 
follicles, consisting of a central B-cell area surrounded by a thinner layer of mainly CD4
+
 
T cells (45, 135). Follicles are present in the gastric mucosa of virtually all infected 
individuals, but their function is still unknown (45). H. pylori specific IgA antibodies are 
produced both locally and systemically (91, 92). A T-cell response is also induced and 
interferon-γ (IFN-γ) producing helper T cells seem to be an important component of the 
response (8, 11, 30, 84). However, recent data suggest that interleukin-17 (IL-17) 
producing helper T cells as well as regulatory T cells may also play important roles 
during infection (105). 
 
General properties of CD4
+
 T -cell responses 
CD4
+
 T helper (Th) cells activate and coordinate other cellular components of the 
immune system. Three types of Th cells have been recognized so far; Th1, Th2 and Th17 
cells. In addition, T cells with suppressive function are also found among the CD4
+
 T 
cells (Figure 2). 
 T helper1 (Th1) cells are important for protection against intracellular bacteria and 
are characterized by secretion of IFN-γ and tumor necrosis factor-α (TNF-α), which 
stimulate the microbicidal activities of macrophages and dendritic cells. IFN-γ also acts 
on B cells to stimulate production of opsonizing IgG antibodies. Th1 cells are induced by 
IL-12, a cytokine produced by natural killer cells, dendritic cells and macrophages (72). 
 T helper 2 (Th2) cells are characterized by secretion of IL-4, IL-5 and IL-13. 
These cytokines promote IgE and eosinophil/mast cell-mediated immune reactions, 
which are protective against helminth infections. Th2 cells are also important for allergic 
reactions against allergens. Th2 cells are induced by the cytokine IL-4 (72). 
 T helper 17 cells constitute the latest subgroup of Th cells that has been discovered. 
Compared with Th1 and Th2 cells, less is yet known about their role. Th17 cells are 
characterized by secretion of IL-17A (IL-17), which can signal to a variety
 
of cell types 
(including epithelial cells, endothelial cells,
 
and fibroblasts) to express IL-8,
 
IL-1β, TNF-
α, and IL-6 (72). This secretion induces mobilization and activation of neutrophils 
leading to a neutrophil rich inflammatory response. Th17 cells are thought to be 
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important in autoimmune diseases but can also protect against extracellular infections, 
including gram-positive Propionibacterium acnes, gram-negative Klebsiella pneumoniae, 
and acid-fast Mycobacterium tuberculosis (61, 68, 72). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Different CD4+ T-cell lineages, their pathways for induction/maintenance and their 
cytokine secretion profiles in humans.   
 
 Naïve cells differentiate to Th17 cells in response to a combination of the 
immunoregulatory cytokine transforming growth factor-β (TGF-β), proinflammatory 
cytokines, such as IL-6 and IL-1β, and/or IL-21 (Figure 2) (77, 149). IL-23 appears to be 
essential for the maintenance of the Th17 phenotype, but does not seem to be directly 
involved in the induction of these cells (72). IL-23 is a heterodimer composed of a unique 
p19 subunit together with a p40 subunit shared with IL-12 and this cytokine was first 
described in early 2000 (107). Data from many earlier studies of the role of IL-12 p40, 
including studies of immunity to H. pylori, need to be reinterpreted based on the new 
knowledge that the p40 subunit is important for induction of both Th1 and Th17 
responses.   
Na ïve CD4 T cell
APC 
Th1 Th2 Th17 iTreg
IFN -γ , TNF -α IL -4, IL-5, IL-13 TGF -β, IL -10 (?)
+
IL-17, IL -22 
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 Regulatory T cells (Tregs) can suppress T helper cells as well as other cells of the 
immune system. CD4
+
 Tregs are now categorized into two main classes; naturally 
occurring Tregs, which develop their regulatory function in the thymus, and regulatory T 
cells that gain their regulatory function in the periphery or in vitro, i.e. induced Tregs 
(iTreg) (125). Upon TCR stimulation, a naive CD4
+
 T cell can be driven to express the 
transcription factor FOXP3 and become a Treg cell in the presence of TGF-β (71). 
However, if IL-6 or other proinflammatory cytokines are also present, the naïve T cell 
differentiate to become a Th17 cell rather than a Treg cell (Figure 2). Treg suppression 
has been demonstrated to be critically dependent on IL-10 and/or TGF-β in vivo (125). 
However, in vitro, suppression has been shown to be contact dependent (14). A link 
between the contact and cytokine dependent mechanisms of Treg suppression was 
described when surface bound TGF-β was found to be important for suppression (99). 
However, these results have later been questioned (110) and the mechanism of Treg 
mediated suppression remains to be fully clarified. In humans, Tregs have been 
recognized to be T cells with high expression of the IL-2 receptor α-chain, CD25, and the 
transcription factor FOXP3 (146). In addition, there are also Tr1 cells, characterized by 
high IL-10 production (14) and Th3 cells which produce high levels of TGF-β (55), but 
the relation between the different types of suppressive T cells is still unclear.  
 
T-cell responses to H. pylori infection 
Several different T-cell subsets infiltrate H. pylori infected mucosa and are likely to 
contribute to and regulate the immune response to H. pylori infection. Murine studies 
have shown that the gastric inflammation is T-cell dependent, as H. pylori does not 
induce gastritis in T-cell deficient mice (36). Early studies that investigated T- cell 
responses to H. pylori in humans showed that, in healthy controls as well as in H. pylori-
infected individuals, peripheral blood-derived T cells proliferated in response to 
stimulation with H. pylori-derived antigens, including whole bacteria (67) and crude 
membranes or cytoplasmic proteins (16). In the human gastric mucosa, H. pylori induces 
recruitment of increased numbers of CD4
+
 T cells (8, 131).  
 The mucosal inflammation induced by H. pylori has for many years been 
considered to be primarily of a Th1 type. Freshly isolated lymphocytes and T cell clones 
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derived from H. pylori infected mucosa were shown to secrete IFN-γ (11, 30, 84), and 
studies in IL-4- and IFN-γ-deficient mice confirm the role of Th1 cells in perpetuating the 
development of inflammation associated with H. pylori infection (127). Recently, several 
studies
 
have reported that IL-17 is expressed in the stomach of H.
 
pylori-infected humans 
and mice, which
 
suggests that a Th17 response may also be elicited by the infection (22, 
95). Both IL-23/p40 and p19 subunits are also upregulated in biopsies of H. pylori-
infected individuals, indicating that IL-23 may contribute to the Th17 response (22, 72). 
 However, the T helper cell response to H. pylori may be counteracted by the 
activity of Tregs. Previous studies have shown that stimulation of peripheral blood CD4
+
 
T cells with a membrane preparation of H. pylori in vitro results in responses in both 
infected and uninfected subjects, but that the memory T cells from infected subjects 
responded less compared to that seen in noninfected controls (83). This 
nonresponsiveness to H. pylori was abolished upon removal of CD4
+
CD25
high
 Treg cells, 
indicating the relevance of these Treg cells in suppressing the proliferative response. 
Furthermore, functionally suppressive FOXP3
+
 Tregs have been shown to home and 
accumulate in the H. pylori-infected gastric mucosa (37, 83) and increased expression of 
the suppressive cytokines TGF-β and IL-10 have been observed in infected compared to 
uninfected mucosa (8, 80). In mice, lack of Tregs has been shown to be associated with 
increased gastritis and reduced H. pylori colonization (115), supporting that under normal 
conditions, Tregs may contribute to the inability to clear the infection. 
 
B-cell and antibody responses to H. pylori infection  
Almost all H. pylori infected individuals have antibodies against whole bacteria (101) as 
well as against a number of purified antigens, including flagellin, urease, 
lipopolysaccharide (LPS), neutrophil activating protein, the putative adhesin 
Helicobacter pylori adhesin A (HpaA) and membrane protein preparations both in serum 
and locally in gastric aspirates (92). Furthermore, H. pylori infection results in significant 
increases in plasma cells in the gastric mucosa which primarily produce IgA (91); e.g. in 
Swedish adults chronically infected with H. pylori, more than 40-fold higher numbers of 
IgA and IgG antibody secreting cells (ASC) were observed in the antral mucosa 
compared to the stomach of non-infected subjects (91). H. pylori specific IgA antibodies 
19 
 
have also been detected in saliva, gastric juice and feces from H. pylori infected 
individuals (49). In addition, the expression of the secretory component on epithelial cells 
is higher in H. pylori infected than in non-infected mucosa (3), suggesting that increased 
levels of secretory IgA is transported into the lumen during infection. The role of these 
antibodies is unclear but secretory IgA antibodies may be efficient in neutralizing e.g. 
urease and VacA as well as in inhibiting adherence of H. pylori to the mucosa (27).  
 
Protective immune responses against H. pylori 
Despite the T- and B-cell responses induced by H. pylori, the infection is chronic in both 
humans and mice. However, studies in mouse models of H. pylori infection show that the 
infection can be prevented, and established infections eradicated by many different types 
of immunizations. There is clear evidence that CD4
+
 T cells are required for 
immunization induced protective immunity against the infection. Thus, mice lacking 
MHCI, but not MHCII, are protected against H. pylori infection after immunization, 
suggesting that CD4
+
 but not CD8
+
 T cells are required for effective immunity (38, 108). 
Although there is strong evidence that IFN-γ is important for development of gastritis and 
for controlling the bacterial colonization in unimmunized mice (43, 123, 127), the role for 
IFN-γ in immunization induced protection is less clear. Although IFN-γ deficient mice 
fail to develop protection after immunization in some studies (6), immunization induced 
protection has been demonstrated in such mice in other reports (43, 123). Furthermore, 
studies showing that IL-12p40 knockout mice, which are deficient in IL-23 as well as IL-
12 production, are not protected against H. pylori infection after immunization (6, 43), 
suggest that the Th17 cell subset may also play a role in protection against H. pylori (6, 
43). More recent studies confirm this notion, since IL-17 neutralization or neutrophil 
depletion inhibits vaccine-induced reduction of H. pylori colonization (32, 144). Some 
studies also suggest that Th2 responses are important for protection (96), although this 
remains controversial (2, 6). 
 The role of antibodies for immunity against H. pylori is less clear than the role of 
CD4
+
 T cells. Czinn et al. showed that preincubation of bacteria with urease specific 
monoclonal antibodies decreased the bacterial infectivity (29) and Nystrom et al. 
observed a direct relation between protection and IgA levels in the stomach (103). 
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Furthermore, there are some indications that antibodies may reduce the gastritis because 
mice lacking antibodies have more gastritis and also clear the infection quicker than wild-
type mice (7). On the other hand, knockout studies have shown that mice lacking 
antibodies are equally well protected against challenge as wild-type mice (38, 132). In 
addition, it has been demonstrated that the prevalence of H. pylori infection does not 
differ between IgA deficient and normal Swedish individuals (19). However, patients 
with IgA deficiency are at increased risk of developing gastrointestinal carcinomas (41). 
A recent study has also shown that gastric adenocarcinoma patients have decreased 
production of gastric IgA antibodies which may have an impact on the development of 
disease (114). However, it is not known whether this low IgA production is a cause or 
effect of development of gastric malignancy.  
 
H. pylori infection in children 
The majority of H. pylori infections are acquired during the first decade of life (40, 94). 
A major risk factor for acquisition of H. pylori infection is low socioeconomic status of 
the family during childhood, e.g. high numbers of persons in a household (person to 
person transmission), sharing of bed, poor sanitation and personal hygiene (fecal-oral 
transmission) (70).  
 
H. pylori-induced diseases in children 
Although H. pylori is etiologically associated with chronic active gastritis, peptic ulcers 
and gastric adenocarcinoma, duodenal ulcers are usually not seen before young adulthood 
or at mid life and gastric cancer is primarily seen in people over the age of 50 (13, 52). 
Thus, although children develop chronic gastritis, this is generally an asymptomatic 
condition and symptomatic diseases are infrequent. At present, there is no evidence to 
suggest a link between H. pylori gastritis and pain in the abdomen in children (13). 
 
T-cell responses to H. pylori in children 
There are a few reports describing the lymphocyte subsets present in the gastric mucosa 
of children infected with H. pylori. These studies show that the stomach mucosa is 
infiltrated by increased numbers of mononuclear cells and CD3
+
 T cells in H. pylori 
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infected compared to uninfected children (20, 58). It has been also reported that elevated 
levels of IFN-γ, IL-17, IL-12 and IL-8 are found in infected mucosa of children (20, 86). 
In contrast, the levels of the Th2 cytokines IL-4 and the regulatory cytokine IL-10 do not 
differ between H. pylori infected and uninfected children (86). In a recent report, 
infiltration of cytotoxic T lymphocytes was found to be more prominent in children with 
a high risk for gastric cancer than in children from a low-risk population (13). The 
predominance of cytotoxic T lymphocytes in risk group children suggests that they may 
predispose to more severe damage in such high-risk populations. However, some 
investigators (58, 148) have reported that H. pylori associated gastritis in children is 
reduced compared with that of adults, possibly as a result of the presence of high 
numbers of Tregs in the gastric mucosa of children (58). It has been suggested that local 
Treg cell activity in children down-regulates the Th1-mediated inflammation typical of 
H. pylori-associated gastritis in adult hosts. This suppression is consistent with the 10-
fold lower level of IFN-γ found in the gastric mucosa of children compared with that of 
adults (20). 
 
Antibody responses in children 
There are very few studies on antibody responses to H. pylori in young children, both in 
high endemic and low endemic countries. In a study in a rural area in Egypt, 13% of the 
children at 7-9 months of age were positive for IgG antibodies against H. pylori urease 
using a commercial ELISA test (12). By 18 months of age seropositivity had increased to 
25%, whereas 88% of the mothers were positive using the same assay. When IgG 
antibody responses to H. pylori were compared in children and adults in Mexico (142), it 
was found that 37% of the children below 10 years of age were seropositive (IgG titers 
against whole cell antigen) as compared to 89% of the adults. Furthermore, a 
considerably lower frequency of the children in this study had significant IgG antibody 
levels against CagA (47%) and urease (16%) than the adults (79% and 59% respectively). 
In recent studies in East Europe, where the prevalence of H. pylori also is high (65), 79% 
of 8-16 year old Lithuanian children with gastritis or duodenal ulcers were histologically 
positive for H. pylori. Of these positive children, 57% had increased IgG antibody levels 
against H. pylori as detected using a low molecular weight antigen preparation and adult 
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cut-off levels in the ELISA test (65). However, adult cut-off levels may sometimes result 
in lower sensitivities in children than in adults (23, 28, 31), which could explain the 
comparatively low seropositivity in this study. Studies of IgG antibody responses to H. 
pylori in asymptomatic school children in Germany with a mean age of 11 years reached 
a seropositivity of 20% using ELISA (18). A significantly higher level of seropositivity 
was observed among children of Turkish (38%) compared to German nationality (14%) 
(18). A very low level of  responders to H. pylori have also been observed in Swedish 
children, with only 3% being seropositive at 11 years of age (54). 
 
Role of breast feeding for protection against H. pylori infection 
A role of breast milk antibodies for protection against H. pylori infection has been 
suggested. In a study in Gambian infants, intake of high levels of anti-H. pylori IgA 
antibodies in breast milk was associated with delayed age of onset of H. pylori infection 
(138). It has also been suggested that urease antibodies may protect against colonization 
with H. pylori during infancy (138). Furthermore, human milk has been shown to inhibit 
the adherence of H. pylori to a gastric adenocarcinoma cell line by 50-70% (26) and 
lactoferrin from human breast milk binds to H. pylori LPS leading to its inactivation (9). 
In a recent meta-analysis on the role of breast milk for protection against H. pylori, it was 
concluded that breastfeeding is protective, especially in LMIC, probably due to high 
levels of specific IgA antibodies in mother’s milk (24). 
 
In this thesis we have studied the development of B- and T-cell immune responses to H. 
pylori in young infants in a highly endemic area for H. pylori and the role of maternal 
antibodies and the childrens’ own immune responses for protection against infection. We 
have also compared immune responses to H. pylori in adults in a high and low endemic 
area. 
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AIMS OF THE STUDY 
 
The overall aim of this thesis was to analyze humoral and cellular immune responses to 
H. pylori in children and adults living in a developing country with a high prevalence of 
H. pylori infection. The specific aims were:  
 
• to analyze and compare immune responses to H. pylori in infected Bangladeshi 
and Swedish adults. 
 
• to establish simple approaches for detection of H. pylori infection in infants and 
young children in a developing country setting. 
 
• to determine the incidence of H. pylori infection in Bangladeshi children during 
their first two years of life in relation to season, blood group, nutritional status and 
co-infection with enteric pathogens.  
 
• to study the development of systemic and mucosal antibody responses to H. pylori 
infections acquired during infancy and early childhood.  
 
• to evaluate the relation between maternal antibodies and acute H. pylori infection 
during infancy. 
 
• to determine if certain T-cell responses (Th1 and Th17) may contribute to the 
immune responses against H. pylori in young children and adults.  
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MATERIALS AND METHODS 
Study sites 
The studies described in this thesis were performed in two different areas in Bangladesh; 
in Dhaka city and in Mirpur, 10 miles west of Dhaka city center, as well as in 
Gothenburg, Sweden. Bangladesh, on the Northern coast of the Bay of Bengal, has a 
subtropical monsoon climate characterized by high humidity and wide seasonal variations 
in rainfall and temperatures. Three seasons are generally recognized: a hot, humid 
summer from March to June; a cooler, rainy monsoon season from June to October; and a 
cool, dry winter from October to March.  
 For comparison of immune response against H. pylori in high and low endemic 
areas (Paper I), we recruited infected patients with duodenal ulcers (DU) and 
asymptomatic (AS) carriers without symptoms of the infection in Dhaka city and AS 
participants and H. pylori-negative subjects in Gothenburg (Table 2). The Bangladeshi 
AS subjects were recruited at the International Centre for Diarrhoeal Disease Research, 
Bangladesh (ICDDR,B) and DU subjects were recruited from in and around Dhaka city 
via the Dhaka Medical College Hospital. Swedish AS and H. pylori negative participants 
were recruited among blood donors at the Sahlgrenska University Hospital (SUH) in 
Gothenburg.  
 For analysis of the epidemiological features of H. pylori infection during the first 
two years of life and for studies of the development of immune responses against the 
infection (Paper II, III), samples were collected from children participating in a 
prospective community based birth cohort study conducted in the Mirpur field area in 
Bangladesh from April 2002 to October 2004 (112) (Table 2). The area of Mirpur is 
around 90 sq km and is densely populated with 2.5 millon inhabitants, corresponding to 
about 20% of the population in Dhaka city. We chose the Mirpur site for our studies since 
it is representative of low to middle income community, where our laboratories have 
experience in carrying out a large number of field and laboratory based studies over the 
last 15 years. For the studies of T-cell cytokine responses to H. pylori (Paper IV), 
children and adults were recruited from the same field area (Table 2).  
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Participants and collection of specimens 
Studies of B- and T-cell responses in adults (Paper I) 
To compare B- and T-cell immune responses to H. pylori in high and low endemic areas, 
adult H. pylori-infected DU and AS participants were recruited to the study in both 
Bangladesh and Sweden (Table 2). Due to the high prevalence of H. pylori infection in 
Bangladesh, it was difficult to recruit uninfected Bangladeshi individuals. Instead, 
uninfected Swedish participants served as controls. AS subjects or uninfected controls 
had no signs of ulceration at the time of endoscopy and did not have any gastrointestinal 
symptoms or illness during the preceding three weeks. The DU patients had at least one 
visual ulcer in the duodenum at the time of endoscopy. None of the participants were on 
any medication during the preceding three weeks before enrollment. 
 
Table 2. Characteristics of participants in the different studies. 
Papers No of 
participants 
Ages Study sites Samples collected 
15
 a
 20-60 years Dhaka (AS) 
24 18-42 years Dhaka (DU) 
14 31-61 years Gothenburg (AS) 
Paper I 
16 22-63 years Gothenburg (Hp
-
) 
Blood, stool, antral 
and duodenal 
biopsies 
238 0-24 months Mirpur, Dhaka Blood, stool Paper II, III 
44 18-35 years Mirpur, Dhaka Blood, breast milk 
16 6-12 months Mirpur, Dhaka Blood, stool 
10 3-5 years Mirpur, Dhaka Blood, stool 
15 19-32 years Mirpur, Dhaka Blood, stool 
1 25 years Dhaka (Hp-) Antral biopsies 
7 46-89 years Gothenburg (Hp
+
) Antral biopsies 
Paper IV 
6 57-77 years Gothenburg (Hp
-
) Antral biopsies 
a 
Six of these individuals were also included in Paper IV for analysis of mRNA levels. 
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 Blood samples from Swedish and Bangladeshi subjects and stool samples from the 
Bangladeshis were collected prior to enrollment in the study for preliminary H. pylori 
diagnosis (see below). Biopsies were collected from both the antral and the duodenal 
mucosa of all participants by gastroduodenal endoscopy. Biopsies from the antrum and 
duodenum respectively were embedded in optimal cutting temperature compound (OCT), 
immediately snap-frozen, and used for immunohistochemistry (IHC). Biopsies from each 
site were fixed in formalin and used for histological examination. From a subset of the 
participants, 1-2 biopsies were stored at -70
ο
C for protein analysis using a saponin 
extraction method (15). The remaining biopsies from each site were pooled and used for 
isolation of lymphocytes and subsequent flow cytometric (FCM) analyses. Blood 
specimens were collected from all participants on the day of endoscopy.  
 Samples collected in Bangladesh for this study (Paper I), (except for the samples 
used for flow cytometry) were shipped to Sweden in dry ice for analysis and kept frozen 
at all times; control experiments were performed in Bangladesh and Sweden to verify that 
similar results were obtained before and after transportation. 
 
Birth cohort studies (Paper II, III) 
For the epidemiological and immunological H. pylori studies in young children from 
birth up to 2 years of age, 238 children were enrolled (Table 2, Paper II) (112). We also 
analyzed immune responses against H. pylori infection, reinfection and spontaneous 
eradication in these children (Paper III). The general health status of the children at the 
time of inclusion in the study was assessed by a study physician. 
 Fecal specimens were collected from each child every month and blood at three 
month intervals (Figure 3). In addition, cord blood was collected just after birth. Samples 
collected every sixth month, or in a subset of children every third month, were tested for 
H. pylori using a stool antigen test. Blood samples from the mothers were collected every 
6 month and breast milk every third month. All samples were transferred cold from 
Mirpur to the laboratory at ICDDR,B and stored at -70
ο
C until laboratory tests were 
performed in the same laboratory.  
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Figure 3. Schematic diagram of time points for analysis of specimens from children (Ch) and 
mothers (Mo) in the birth cohort studies (Paper II & III). Bold symbols (+) indicate time points 
when specimens from all children were analyzed (n=238). “+” indicates time points when 
samples from selected children (n=50) and mothers (n=20-44) were analyzed. 
 
Cytokine studies in children and adults (Paper IV) 
For analysis of cytokine production by T cells in response to stimulation with H. pylori 
antigens, H. pylori-positive and H. pylori-negative adults (19-32 years), children (3-5 
years) and infants (6-12 months) were recruited in the Mirpur field area in Bangladesh 
(Table 2). Only AS participants who did not have any symptoms of the infection and did 
not have any illness during the preceding three weeks before participation were enrolled. 
Blood cells were stimulated with different antigens and collected culture supernatants 
were analyzed either in Gothenburg or in Dhaka. Some randomly selected supernatants 
were analyzed in both Sweden and Bangladesh as a control experiment and we observed 
similar results in the two different laboratories. Stool and blood samples were collected 
once from each volunteer.  
 
Detection of H. pylori infections (Paper I-IV) 
For preliminary diagnosis of H. pylori infection in Swedish and Bangladeshi participants, 
plasma samples were screened at the respective site for presence of H. pylori-specific IgG 
antibodies using an in-house enzyme-linked immunosorbent assay (ELISA) (15, 92). In 
Bangladeshi children and adults, the H. pylori status was also analyzed using a 
monoclonal antibody based test for detection of H. pylori specific antigen in the stool 
(Amplified IDEIA Hp StAR, Dako, Denmark). For some of the Bangladeshi and Swedish 
adults (Paper I), infection was later confirmed by culture of biopsies on horse blood-
 
Ch stool             +      +             +             +             +              +              +               +                +               50/238 
Ch blood  +           +             +             +              +              +              +                +                +         
  0   1       3             6              9            12            15             18              21              24 Month 
Mo breast  
milk 
 +           +             +             +               +                                                              
50 
Mo blood       +                       44 
20 
Time 
n 
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Columbia Iso agar plates at 37°C under microaerobic conditions (10% CO2, 5% O2, and 
85% N2); after 3 days of culture, H. pylori bacteria could be detected from the vast 
majority (>90%) of H. pylori seropositive participants but not from any of the 
seronegative individuals. When H. pylori bacteria could not be cultured from seropositive 
individuals, infection was confirmed by stool antigen test (in Bangladesh) or by urea 
breath test (in Sweden).  
 
Analysis of H. pylori specific antibodies (Paper I-IV) 
Titers of H. pylori-specific IgA and IgG antibodies in plasma, breast milk, stool extracts 
and biopsy extracts were determined by the in-house ELISA tests as previously described 
(15, 92). A membrane protein preparation (MP) from the H. pylori strain Hel 305 isolated 
from a Swedish duodenal ulcer patient was used as coating antigen. For some serological 
analyses (Paper I), MPs from Bangladeshi H. pylori strains were also used. The MPs 
were prepared by sonication of the bacteria followed by differential centrifugation, as 
previously described (1). The total amounts of IgA in mucosal biopsy extracts and plasma 
were determined using ELISA (15).  
 
Cell isolation (Paper I & IV) 
For analysis of lamina propria lymphocytes (LPLs), cells were isolated from the biopsies 
by incubation in EDTA/DTT and subsequent collagenase/DNase treatment, as previously 
described (83). Initial experiments showed that this cell isolation protocol gave a 
maximal yield of cells, with little of the epithelium remaining in the lamina propria 
fraction, and that the isolation procedure had only marginal effects on the expression of 
different cell surface markers. 
 For analysis of T-cell cytokine responses, peripheral blood mononuclear cells 
(PBMCs) were isolated from blood collected in heparinized vials by gradient 
centrifugation on Ficoll-Isopaque. Plasma collected from the top of the Ficoll gradient 
was stored in aliquots at -20
ο
C for antibody assays. 
 In additional experiments, CD4
+ 
T cells were depleted from the PBMCs to 
determine the T-cell subset responsible for cytokine production using Dynal (CD4
+
) 
beads according to the instructions provided by the manufacturers. CD4
+
 T cells were 
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also isolated by detaching the T cells from the beads according to the instructions 
provided. 
 
Flow cytometry (Paper I & IV) 
LPLs and PBMCs were stained with fluorescently labeled antibodies. Cells were fixed in 
formaldehyde before FCM analysis, which was performed on FACSCalibur instruments 
in both Bangladesh and Sweden. Calibrite beads (BD Pharmingen) were used to achieve 
comparable settings on the two machines used in Bangladesh and Sweden. Control cell 
samples were run on the two machines by the same operator to ensure consistent results.  
 The FCM data were analyzed with FlowJo software (Tree Star Inc.). The number of 
cells isolated from pooled biopsies from each individual was estimated by multiplying the 
frequency of positive cells detected by FCM with the total number of lymphocytes 
isolated from each biopsy. FCM data from analysis of PBMCs were reported as 
frequencies of cells.  
 
Histopathology (Paper I) 
For histological analysis of mucosal samples, biopsies collected from the antral and 
duodenal mucosa from both Swedish and Bangladeshi adults were fixed in formalin, 
embedded in paraffin and routinely processed for histology at the pathology unit at SUH 
in Sweden. The inflammation was graded on a scale from 0-3, corresponding to none, 
mild, moderate and severe inflammation, according to the Sydney system (111). 
 
Immunofluorescence (Paper I)  
To analyse the numbers of Treg in mucosal biopsies, CD4
+
 T cells expressing the Treg 
marker FOXP3 were stained using fluorescent labeled anti-FOXP3 and anti-CD4 
antibodies (DAKO, Glostrup, Denmark), as described (37). The numbers of positive 
CD4
+
FOXP3
+
 cells in the lamina propria in each section were counted using a Zeiss 
Axiovert 100TV fluorescent microscope. The total areas of the sections were measured 
using Zeiss Axiovision software and the number of positive cells was expressed per 
square millimeter of total tissue area.  
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Anthropometric analyses (Paper II) 
To determine the relationship between malnutrition and H. pylori infection in children, 
the nutritional status of the children in the birth cohort study was assessed at birth and at 
1, 6, 12, 18 and 24 months of age. Children who were undernourished (<-2SD of weight 
for age) or stunted (<-2SD of height for age) were identified by comparison with the 
weight and height of the National Center for Health Statistics reference population of the 
same age and sex. 
 
Identification of other enteric infections (Paper I-III) 
The monthly stool samples collected from the Bangladeshi participants in the birth cohort 
and adult studies were analyzed for enterotoxigenic Escherichia coli (ETEC) using GM1-
ELISA for LT and ST expression and dot blot analysis of colonizing factor antigens 
(126). The stool samples were also cultured for other enteric pathogens, e.g. Vibrio 
cholerae O1/O139, Salmonella, Shigella and Campylobacter spp., as well as analyzed for 
rotavirus by ELISA and tested by direct microscopy to detect cyst and vegetative forms 
of parasites and ova of helminths. 
 
Blood grouping (Paper II) 
Blood specimens collected from the children in the birth cohort study were typed for 
ABO blood group and Rh factors using a slide agglutination procedure using antisera 
from Biotech Laboratories, Suffolk, UK.  
 
Recording of breast feeding practices (Paper II-III) 
Mothers of children participating in the birth cohort studies were asked every month by 
the field attendants about their breast feeding practices and the data were recorded. All 
children were breastfed for at least 6 months. Children who during the initial 6 months of 
life received breast milk only were termed as ‘exclusively breast fed’ and children who in 
addition were also fed with water, honey or sugar syrup were designated “partially breast 
fed”. After 6 months of age, children were breast fed in varying degrees up to 2 years.  
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T-cell stimulation assays (Paper IV) 
For analysis of cytokine responses, isolated PBMCs and PBMCs depleted of CD4
+
 T 
cells were incubated in 96-well U-bottomed tissue culture plates in DMEM medium 
(Invitrogen AB, Sweden) with 5% human serum and 1% gentamycin at 37
ο
C in 5% CO2 
for 5 days. PBMCs were stimulated with H. pylori MP (Hel 305 MP, 1 µg/ml), and 
phytohemagglutinin (PHA, 1 µg/ml) for 5 days. In addition, CD4+ cells were stimulated 
with anti-CD3/CD28 coated expansion beads at a bead to cell ratio of 1:1. After 5 days, 
100 µl supernatants were collected from all cultures and the samples were frozen 
immediately in aliquots at −70
ο
C until assayed for cytokines.  
 
Analysis of chemokines and cytokines (Paper I & IV) 
For analysis of different chemokines in mucosal tissues, proteins
 
were extracted from 
biopsies by incubation of the tissue in 2% saponin solution overnight at 4°C (15). The 
concentrations
 
of the chemokines IP-10 (CXCL9), MIG (CXCL10) and IL-8 (CXCL8) in 
the extracts were
 
determined by the cytometric bead array (CBA, BD
 
Pharmingen). The 
concentration of MDC (CCL22) was measured using
 
ELISA (R&D Systems). The total 
protein concentrations in
 
the extracts were measured by the Bio-Rad protein assay 
(Hercules, CA). 
 To determine the levels of different cytokines in culture supernatants (Paper IV), we 
performed ELISAs for IL-17A (ebioSciences, USA) and IL-13 (R&D, Sweden) 
according to the instructions provided by individual manufacturers and we used CBA for 
analysis of IFN-γ, TNF-α, IL-10, IL-5, IL-4 and IL-2 (BD Pharmingen).  
 
Cytokine gene expression analysis (Paper IV) 
RNA was isolated from RNALater-stabilized human tissue specimens Qiagen's RNeasy 
Mini kit and used for cDNA synthesis using the Omniscript Reverse Transcription kit 
(Qiagen). The relative expression of IL-17 and IFN-γ mRNAs was subsequently 
determined with quantitative real-time PCR gene expression assays from Applied 
Biosystems using HPRT as an internal reference gene. Gene expression changes data 
were analyzed using the ∆∆Ct method, calculating fold change of each gene, normalized 
to the reference gene and relative to an external calibrator sample. 
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Data analyses (Paper I-IV) 
Data were analyzed using the statistical programs GraphPad PRISM 4.0, EpiInfo version 
2000, SPSS for Windows (Version 10.00) and SigmaStat 3.1 (SPSS Systat software, Inc). 
Paired samples were assessed by the Wilcoxon signed rank test, non-paired samples by 
the Mann-Whitney U-test and proportion of responses using the Chi-square or the Fisher 
exact test. In addition, the Chi-Square or Fisher exact tests were also used for comparison 
of epidemiological differences in H. pylori positive and negative subjects (Paper II, III). 
For multiple comparisons, Kruskal-Wallis test with Dunn’s post hoc test was used (Paper 
I). P values <0.05 were considered to be statistically significant.  
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 RESULTS AND COMMENTS 
 
Comparison of humoral and cellular immune responses to H. pylori in infected 
Bangladeshi and Swedish adults (Paper I) 
Most studies of immune responses to H. pylori have been performed in developed 
countries. However, nowadays H. pylori infection is becoming rare in most of the 
developed world. Therefore, we initiated a study in Bangladesh, where the prevalence of 
H. pylori infection is very high, to determine if immune responses to H. pylori may be 
different in a highly endemic country to in a low endemic country. To this end, we have 
analyzed immune responses in adults living in Bangladesh and Sweden. We also 
compared immune responses to H. pylori in AS carriers and in DU patients in 
Bangladesh to investigate if there are immune responses that may be related to 
development of DU disease. 
 
Comparison of immune responses to MP antigens prepared from Bangladeshi and 
Swedish H. pylori strains for use in immunoassays (Paper I) 
To establish an ELISA assay that could be used for determination of antibody responses 
in Swedish and Bangladeshi subjects, a membrane protein (MP) preparation from the H. 
pylori strain Hel 305 isolated from a Swedish DU patient was compared with MPs from 
several different H. pylori strains isolated from Bangladeshi participants. The Hel 305 
MP preparation has been extensively used in studies in Sweden (91, 92, 114, 141). Sera 
from both Bangladeshi and Swedish H. pylori-infected participants reacted with both the 
Bangladeshi and Swedish strain MPs, but the antigen prepared from the Swedish strain 
gave consistently higher antibody titers than the MP prepared from Bangladeshi strains 
(exemplified in Figure 4 for strain D94 isolated in Bangladesh). Since we observed 3-6 
fold higher H. pylori-specific IgA antibody titers against Swedish MP in sera from both 
Bangladeshi and Swedish asymptomatic participants than against the Bangladeshi MP 
tested, we chose Hel 305 MP as coating antigen in our studies. The same MP was also 
used to study T-cell responses (Paper IV). 
 By performing the ELISA tests on sera from H. pylori infected subjects, we also 
observed that the titers of H. pylori-specific IgA (Figure 4) and IgG (not shown) 
antibodies were about twofold lower in the Bangladeshi compared to in the Swedish 
samples. As most of the Bangladeshi participants included in the study were probably 
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less well nourished, the nutritional status may explain at least some of the serological 
differences observed between Bangladeshi and Swedish participants. 
 
 
 
Figure 4. Comparison of ELISA titers against 
MP prepared from Bangladeshi (strain D94) and 
Swedish (strain Hel 305) H. pylori bacteria, 
respectively (geometric mean values + SEM). 
IgA antibody titers in sera from adult 
Bangladeshi (black bars; n=10) and Swedish 
(white bars; n=20) participants are shown. 
(**P<0.01, ***P<0.001). 
 
 
 
 
 
Mucosal inflammation in Bangladeshi and Swedish adults (Paper I) 
Our observation of different levels of serum antibody responses to H. pylori in the 
different populations encouraged us to also investigate the mucosal inflammatory 
responses against H. pylori in Swedish and Bangladeshi subjects. This was done by both 
histological analysis of biopsy material and analysis of antibodies extracted from the 
biopsies. As >90% of Bangladeshi adults are infected by H. pylori, it was very difficult to 
recruit uninfected Bangladeshis and we were able to recruit only one uninfected control 
in Bangladesh (not included in Paper I but shown in this thesis). Instead, we primarily 
compared immune responses in H. pylori-infected Bangladeshi subjects with responses in 
Swedish infected and uninfected participants.  
 We isolated similar numbers of LPLs from antral biopsies from Bangladeshi and 
Swedish H. pylori-infected AS individuals (Figure 5a), indicating a comparable 
infiltration of cells into the antral mucosa of subjects from both countries. However, 
significantly lower numbers of LPLs were isolated from uninfected gastric mucosa of H. 
pylori-negative Swedes; similarly low cell numbers were isolated from the uninfected 
Bangladeshi control individual, supporting the observation that the higher lymphocyte 
numbers observed in the antrum of infected individuals are a consequence of H. pylori 
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infection in both populations. In contrast, higher numbers of LPLs were isolated from 
duodenal biopsies from Bangladeshi than from Swedish participants (Figure 5b), 
suggesting the presence of more duodenal inflammation in the Bangladeshis. On the 
other hand, the number of LPLs isolated from the duodenum were very similar in 
Swedish AS carriers and H. pylori-uninfected participants (Figure 5b). Histological 
examination of antral and duodenal biopsy material as well as analysis of mucosal 
chemokine levels also to a large extent supported the presence of similar levels of 
inflammation in the antrum, but higher levels in the duodenum of Bangladeshi compared 
to Swedish participants. The presence of higher inflammation in the duodenum of 
Bangladeshi individuals may reflect recruitment of both H. pylori-specific and non-
specific lymphocytes to the duodenum.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Comparison of numbers of lamina propria lymphocytes isolated from antral and 
duodenal biopsies from Bangladeshi H. pylori infected DU (▲) and AS (■) and Swedish H. 
pylori positive AS (♦) and H. pylori negative (▼) subjects. The median values are indicated by 
horizontal lines. Open triangle (∇) shows the level of LPLs in the Bangladeshi H. pylori 
uninfected control. (*P<0.05, **P<0.01; ns: not significant). 
 
Mucosal B- and T-cell responses in Bangladeshi and Swedish adults 
We also studied the relative contributions of different lymphocyte subsets to the 
inflammation. Mucosal cells were analyzed by FCM and in addition, we analyzed the 
levels of H. pylori-specific and total IgA in mucosal tissue extracts by ELISA. 
Sweden Bangladesh Sweden Bangladesh 
DU AS AS HP- 
1 
3 
5 
7 
L
P
L
s 
(x
1
0
 5 )
/b
io
p
sy
 
DU AS AS HP- 
1 
2 
3 
4 
5 ns ns ** ns * ns 
a b 
L
P
L
s 
(x
1
0
 5 )
/b
io
p
sy
 
Antrum Duodenum 
36 
 
Comparable numbers of CD19
+ 
B cells and similar levels of H. pylori-specific IgA 
antibodies were observed in the antrum of H. pylori infected Bangladeshi and Swedish 
participants. The numbers of CD4
+
 and CD8
+
 T cells and FOXP3
+
 Tregs were also 
similar in the gastric mucosa of these study groups. Higher numbers of CD19
+ 
B cells, H. 
pylori specific IgA antibodies and CD4
+
 T cells and similar levels of CD8
+ 
T cells were 
isolated from the stomach of infected compared to uninfected Swedes. In contrast, about 
3-fold higher numbers of CD19
+
 B cells and 12-fold increased levels of H. pylori-specific 
IgA antibodies were found in the duodenum of the Bangladeshi subjects compared to in 
the Swedish volunteers. However, the numbers of T cells were similar in duodenal 
biopsies from the different study groups. The numbers of CD19
+ 
B cells, CD4
+ 
T cells, 
CD8
+ 
T cells and levels of specific IgA were low and comparable in the duodenum of 
both H. pylori-infected and uninfected Swedish participants. 
 Taken together, our results show a lower systemic antibody response to H. pylori, 
but no major differences in immune responses in the stomach mucosa, in the 
Bangladeshis compared to the Swedish adults. On the other hand, increased inflammation 
with higher numbers of B cells and higher levels of both H. pylori specific and total IgA 
were observed in the duodenum of the Bangladeshis, which may be due to considerably 
higher exposure to other gastroenteric infections in Bangladesh.  
 
Studies of H. pylori infection in infants and young children in Bangladesh from birth 
to two years (Paper II & III) 
Since we found comparable levels of immune responses to H. pylori in Bangladeshi and 
Swedish adults who were chronically infected, we were interested in also studying 
immune responses against acute infection in young children in Bangladesh. Before 
initiating studies of immune responses in this age group, we determined the prevalence of 
H. pylori infection in children in the selected Mirpur study area. This was done by 
following a cohort of children from birth up to 2 years of age for onset and duration of H. 
pylori infection. To allow demonstration of H. pylori infection in young children in this 
poor resource area, simple detection methods for H. pylori were used. Traditional 
diagnostic methods, e.g. endoscopy and UBT, are not practically feasible in this area 
since endoscopy of children for collection of biopsies is not possible and samples for 
UBT need to be sent to well-equipped laboratories abroad. Therefore, we used a 
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combination of tests, e.g. analysis of IgA and IgG antibodies in serum and H. pylori 
antigen in stool.  
 
Determination of H. pylori infection during early childhood using stool antigen test and 
serology (Paper II & III) 
Fifty to 60% of the children in the birth cohort were found to be positive for H. pylori by 
two years of age using stool antigen test and serology. Thus, we had established that H. 
pylori-specific ELISA titer of ≥100 for the IgA isotype and ≥1000 for the IgG isotype 
signified positive serology after titration of sera from stool antigen positive and negative 
children. However, we found that usage of IgG serology for determination of H. pylori 
infection in infants is less suitable. Thus, when analyzing the kinetics of the antibody 
responses in the children, we found that the serum IgG titers decreased rapidly from the 
levels in cord blood during the initial 6 months of life, whereafter they increased in all 
groups during the two year study period. IgG titers also lasted during long periods of time 
after eradication of the infection (Paper III). 
 To evaluate to which extent maternal IgG antibodies had been transferred to the 
children through the placenta, we compared the IgG titers in mother’s blood and in cord 
blood. A very high correlation was observed (P<0.0001; Figure 6); supporting 
transplacental transfer of H. pylori specific IgG antibodies. No IgA titers were observed 
in cord blood. The drastic drop in serum IgG observed during the first 6 months of life 
also supports a maternal origin of the serum antibodies during early infancy. 
 
 
 
Figure 6. Correlation between IgG titers against H. 
pylori MP in mother’s blood and in cord blood (n=32). 
(P<0.0001, r= 0.78, Spearman correlation test). 
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 In contrast to the serum IgG titers, the serum IgA titers in the children were low 
during the initial 6 months and then gradually increased. Furthermore, IgA titer rises in 
the stool antigen negative children were very modest in serum during the study period. In 
addition, IgA titers rose rapidly after infection and decreased if the infection was cleared 
(Paper III). We also observed a highly significant correlation between serum IgG and IgA 
levels in relation to H. pylori infection (Spearman r = 0.73; P<0.0001) at 24 months of 
age. Since IgA is not transferred from the mother during fetal life, maternal antibodies do 
not interfere with the childrens’ serum IgA levels during the initial 6 months of life. 
Therefore, measurement of serum IgA may be a suitable method for detection of H. 
pylori infection in young children. 
 We also compared H. pylori-specific IgA and IgG serum titers in Bangladeshi 
infants (0-12 months), children (>12-24 months) and adults (18-60 years) (Paper I-III; 
Figure 7). Our results show that the levels of antibodies increase with age with the 
highest increases seen for IgG early during childhood and for IgA between childhood and 
adulthood. Adults have about 15-fold higher IgA titers and 3-fold higher IgG titers than 
infants (Figure 7). In the adult subjects, there was no correlation between age and 
antibody levels.  
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Comparison of levels of IgA (a) and IgG (b) antibodies against H. pylori MP (Hel 305 
MP) in sera of Bangladeshi H. pylori infected infants (0-12 months for IgA, 6-12 months for IgG; 
black bars, n=15), children (>12-24 months; white bars, n=30) and adults (18-49 years; grey bars, 
n=32). (**P<0.01, ***P<0.001; ns: not significant). 
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 We also compared the sensitivity, specificity, and positive predictive value of the 
stool antigen test in relation to serology (IgA and IgG) and vice versa. Initially, we only 
compared results from the stool antigen test and IgG serology for detection of H. pylori 
(Paper II). However, due to problems with transplacental IgG, we later also included 
comparison of results from the stool antigen test and IgA serology (Paper III). When 
comparing IgG responses in serum with the responses seen with the stool antigen test, 
using specimens collected between 6 and 24 months of age, the sensitivity was 93% at 18 
months and 100% at any time point during the study period. When IgA responses in 
serum were used as the standard and compared to results obtained with stool antigen test, 
the sensitivities of the serology was 75% at 18 months and 87% at any time point 
between 0 and 24 months (Table 3). The specificities of serum IgA were higher than 
serum IgG in relation to stool antigen test (73-98% for IgA and 47-77% for IgG at 
different time points). The limitation of the stool antigen test is that it may give falsely 
negative results and hence be less sensitive than serology. However, when analyzing 
several stool specimens from the same child the detection rate of H. pylori was 
considerably higher. Hence, we recommend collection of at least 2 stool specimens when 
using the stool antigen test for detection of H. pylori in young children. In conclusion, 
IgA serology in combination with a stool antigen test may be the most accurate and 
feasible approach for detection of H. pylori in settings with less resourceful laboratories. 
 
Table 3. Comparison of stool antigen test and IgA serology for detection of H. pylori at various 
time points in children in the Bangladeshi birth cohort (Paper II & III). 
an= number of children analyzed by both stool antigen test and the in-house serum IgA ELISA test.  
Age (n=50)
a
 Sensitivity Specificity 
Positive 
predictive value 
6 mo Stool vs serology (%) 
Serology vs stool (%) 
50 
25 
94 
98 
25 
50 
12 mo Stool vs serology (%) 
Serology vs stool (%) 
57 
67 
89 
84 
67 
57 
18 mo 
 
Stool vs serology (%) 
Serology vs stool (%) 
65 
75 
81 
73 
75 
65 
24 mo 
 
Stool vs serology (%) 
Serology vs stool (%) 
71 
68 
76 
79 
68 
71 
Any time 
point 
Stool vs serology (%) 
Serology vs stool (%) 
87 
87 
79 
79 
87 
87 
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Association between H. pylori infection and socioeconomic factors, enteric pathogens 
and malnutrition (Paper II) 
As described by others, poor hygiene and overcrowding are factors associated with H. 
pylori infection (25, 88). Therefore, we studied different socioeconomic parameters in the 
Bangladeshi birth cohort children that may be related to H. pylori infection. In analogy 
with others (88), we observed that parents’ literacy (both maternal and paternal) may play 
a significant role for H. pylori infection. We also found that H. pylori-infected children 
were more often infected by multiple enteropathogens, often isolated at different time 
points. Malnutrition did not seem to promote colonization by H. pylori; rather, our data 
indicate that wellnourished children were more susceptible to infection. However, we did 
not enroll severely malnourished newborns weighing less than 2 kg at birth, and can 
therefore not comment on the susceptibility to H. pylori infection in such children. 
 
Association between H. pylori infection and ABO blood group (Paper II) 
It has been reported earlier that individuals with certain ABO blood groups may be more 
susceptible to different enteric infections, e.g. blood group “O” subjects are more 
susceptible to V. cholerae O1 infection than persons with other blood groups (48, 57). 
We observed that children with blood group “A” in the birth cohort study were 
significantly more often infected with H. pylori than children with other blood groups 
(Table 4). When the same birth cohort children were analyzed for enterotoxigenic 
Escherichia coli (ETEC) infections, it was found that individuals having blood groups 
“A” and “AB” were more susceptible to ETEC (Table 4) (112). These associations 
between blood groups and infection with different gastrointestinal pathogens may be 
explained by observations that certain bacterial antigens may bind to blood group 
associated antigens that are expressed on epithelial cells in the small intestine (64).  
 
Table 4. Association between ABO blood group and different gastrointestinal infections. 
Blood group H. pylori ETEC V. cholerae O1 
A + + - 
B - - - 
AB - + - 
O - - + 
+ Indicates that individuals with a specific blood group are more susceptible to the respective infection than 
subjects with other blood groups.   
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Seasonality of onset of H. pylori infection in relation to other gastrointestinal infections 
Seasonal variations of different enteric infections have been reported earlier, e.g. in 
Bangladesh (112) and in different countries in Africa and Latin America (118, 145). 
Therefore, we were interested to examine whether infection with H. pylori also occurred 
more frequently during certain periods of the year. For other gastrointestinal pathogens, 
peak infections are usually observed twice a year in Bangladesh. A similar trend was 
observed for H. pylori infections in the birth cohort study, i.e. most children were 
infected during the spring or autumn (Figure 8). The observed seasonality for H. pylori 
infection may be related to recent findings that H. pylori may be transmitted via vomit 
from patients with diarrhea (66). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Seasonality of onset of H. pylori infection (▲) in the birth cohort compared to infection 
rates with ETEC (◊) and V. cholerae (■) in Dhaka. The ETEC and V. cholerae data were obtained 
from a 2% systemic sampling of patients with diarrhoea visiting the ICDDR,B hospital in Dhaka 
during 2007-2008. 
 
Studies of the development of systemic and mucosal antibody responses to H. pylori 
infection in children (Paper III) 
Studies of immune response to H. pylori in children during their first 2 years of life are 
scarce (50, 54). Since we had observed a very high incidence and prevalence of H. pylori 
infections in the birth cohort in Bangladesh (Paper II), we also studied immune responses 
in relation to H. pylori infection in these children in more details (Paper III). In initial 
studies, we determined serum antibody responses to H. pylori infection in children being 
infected during the first and second year of life. These analyses showed a rapid decrease 
in IgG titers in serum during the initial 6 months in both groups of children and also in H. 
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pylori negative controls. Thereafter, titers increased rapidly during the remaining 2 year 
study period, both in children being infected during the first and second year, although 
children became stool antigen positive between 12 and 24 months had significantly 
higher IgG titers at 6 months than children being infected at ≤12 months of age. IgG titers 
in stool antigen negative children also increased during the study period, although to 
lower mean levels than the stool antigen positive children, probably due to development 
of antibodies cross-reacting with the H. pylori MP antigen used in the serological assays. 
The IgA antibody levels in sera of all children studied were very low before 6 months of 
age but increased thereafter, somewhat more rapidly in children being infected during the 
first year than in those being infected during the second year. The IgA antibody levels 
were significantly higher in the H. pylori stool antigen positive children after infection 
than corresponding levels in age matched H. pylori negative control children. 
 
H. pylori specific antibody responses in spontaneously eradicated and reinfected children 
(Paper III) 
We observed that 11% of the birth cohort children infected between 0 and 24 months of 
age were able to spontaneously eradicate the H. pylori infection. To evaluate if this 
eradication was associated with development of specific immune responses we compared 
specific antibody responses in serum and stool over time in continuously infected (CI) 
children with corresponding responses in spontaneously eradicated (SE) children. We 
also analyzed whether children who were reinfected (RI) had decreased antibody levels 
before reinfection. This was done by measuring serum IgA and IgG as well as stool 
IgA/total IgA levels in the SE, CI and RI children before and after onset of infection.  
 Analysis of H. pylori specific IgA levels in stool showed that stool IgA levels were 
high in most children during their first 3-6 months of life, irrespectively of infectious 
status, and decreased thereafter (Figure 9a-c). This pattern probably reflects 
contaminating breast milk antibodies in the stool samples.  
 Most of the SE children responded strongly in serum IgA to the infection and this 
response seemed to be indicative of the duration of the infection (as exemplified in Figure 
9a). Substantial specific IgA/total IgA responses to the infection were also observed in 
stool specimens collected at ≥6 months in most of the SE children, but those responses 
persisted for shorter periods than the serum IgA antibody responses. Serum IgG antibody 
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levels increased after infection and remained elevated also after clearance of the infection 
(Figure 9a). 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The RI children (as exemplified in Figure 9b), showed decreased immune responses 
shortly before reinfection in all specimens, as compared to the SE children (figure 9a). 
For the RI children we did not observe any persisting levels of serum IgA or stool IgA 
titers after the first infection, suggesting increased susceptibility to infection, possibly due 
to decreased H. pylori specific immune responses.   
 In the CI children, the serum IgA and IgG levels remained very stable during the 
infection (as exemplified in Figure 9c). Although the stool IgA antibodies increased 
transiently after onset of infection, the CI children did not clear the infection (Figure 9c). 
 
Association between antibody levels in maternal blood and breast milk and protection 
against acute H. pylori infection (Paper III) 
We observed a very low prevalence of H. pylori infections in the birth cohort children 
during their initial 6 months of life. Based on this we explored whether transplacentally 
transferred IgG and/or IgA antibodies in breast milk from the mothers may be related to 
Figure 9. Examples of immune responses 
to H. pylori in individual children with 
different types of H. pylori infection; (a) 
infection followed by spontaneous 
eradication, (b) infection followed by 
eradication and reinfection and (c) 
continuous infection. Levels of serum IgG 
(■), serum IgA (▲) and specific IgA/total 
IgA (•) against H. pylori MP antigen. 
Positive stool antigen tests are indicated by 
arrows (↑). 
Child 022
0 3 6 9 12 15 18 21 24
10
100
1000
10000
1
10
100
1000
a.
Age (months)
S
e
ru
m
 a
n
ti
-M
P
 t
it
e
r 
(I
g
A
, 
 I
g
G
)
S
to
o
l Ig
A
/to
ta
l Ig
A
Child 201
0 3 6 9 12 15 18 21 24
10
100
1000
10000
1
10
100
1000
b.
Age (months)
S
e
ru
m
 a
n
ti
-M
P
 t
it
e
r 
(I
g
A
, 
 I
g
G
)
S
to
o
l Ig
A
/to
ta
l Ig
A
Child 063
0 3 6 9 12 15 18 21 24
10
100
1000
10000
1
10
100
1000
c.
Age (months)
S
e
ru
m
 a
n
ti
-M
P
 t
it
e
r 
(I
g
A
, 
 I
g
G
)
S
to
o
l Ig
A
/to
ta
l Ig
A
a b 
 
44 
 
this low prevalence. We have already shown a high correlation between the IgG titers in 
mother’s blood and in cord blood (Figure 6) that clearly suggests transplacental transfer 
of IgG. No IgA titers were observed in cord blood and very low levels of serum IgA were 
noted during the first 6 months of life. These observations, together with the drastic drop 
in serum IgG during the first 6 months, support a maternal origin of most of the serum 
antibodies during infancy.  
 To evaluate whether pre-existing serum IgG and/or IgA antibody levels in the 
children may be associated with delayed onset of infection (“protection”) against H. 
pylori, we analyzed antibody titers in the serum samples collected as close as possible 
before children became stool antigen positive. Such analyses were undertaken both for 
children being infected at ≤12 months as well as for children infected between 12 and 24 
months of age. IgG and IgA titers in the pre- and post-infection sera were compared with 
titers in sera collected at the corresponding time points from age-matched, stool antigen 
negative control children in the birth cohort. These analyses showed that IgG titers in 
preinfection sera of children being infected ≤12 months were significantly lower (P=0.02) 
than in sera from the H. pylori uninfected controls. However, no difference was observed 
between the levels of IgA antibodies in preinfection sera of children being infected this 
early or in sera from the H. pylori uninfected control children. Similarly, IgG and IgA 
titers of children being infected after 12 months of age did not differ significantly from 
the titers of the H. pylori uninfected controls. These results, showed that children with 
high IgG antibody levels in serum are less susceptible to H. pylori infection than children 
with low IgG titers during the first year of life, may suggest a protective role of 
transplacentally derived IgG antibodies.  
 With regard to breast milk antibodies against H. pylori, the levels were comparable 
from 1-12 months of lactation in most of the mothers. We found that children who 
became stool antigen positive during the first months of life drank breast milk that 
contained significantly lower levels of H. pylori specific IgA antibodies than children 
who became stool antigen positive at 6 months (Paper III). No significant association was 
observed between IgA levels in breast milk and serum antibody levels of the mothers, 
excluding the notion that the association between low breast milk IgA titers and early 
onset of infection was due to low levels of transplacentally transferred IgG antibodies. 
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Thus, our results support that increased levels of IgG in cord blood and IgA antibodies in 
breast milk are associated with protection against early onset of H. pylori infection. 
 
Analysis of cytokine and chemokine responses to H. pylori in Bangladeshi children 
and adults (Paper I & IV) 
Our studies of immune responses to H. pylori in young children thus suggest that 
antibodies provided by the mother as well as antibody responses induced by the children 
themselves may be associated with delayed onset and/or clearance of infection. However, 
the antibody responses elicited by the infection may reflect a more general immune 
response, also involving T cells and other components of the childrens´ immune systems. 
Recent studies suggest that both Th1 and Th17 cells may be induced by H. pylori 
infection in adults (21, 85, 95) and that both types of T cells may contribute to vaccine 
induced protection in mice (32, 144). However, little is known about the importance of 
these types of responses in relation to H. pylori infection in young children. Previous 
studies of the cytokine profile of T cells responding to H. pylori have also mainly been 
performed in developed countries. Therefore, we analyzed the cytokine responses to H. 
pylori in both children and adults in Bangladesh.  
 
Mucosal cytokine and chemokine responses in adults (Paper I and IV) 
Analysis of gastric biopsies showed that both IL-17 and IFN-γ mRNA were expressed in 
the gastric mucosa of Bangladeshi as well as Swedish adults (Paper IV). The results also 
suggest that that the expression was induced by H. pylori infection, since the levels of 
both cytokines were higher in infected compared to uninfected individuals. IL-17 induces 
the production of IL-8 (72) and strong correlations have previously been found between 
the levels of IL-17 and IL-8 in H. pylori infected mucosa (95). IFN-γ, on the other hand, 
is a strong inducer of the chemokines IP-10 and MIG and the receptor for these 
cytokines, CXCR3, is mainly expressed by Th1 T cells (74). Consistent with the 
expression of both IL-17 and IFN-γ in the infected gastric mucosa, we found increased 
levels of the chemokines IL-8, IP-10 (Figure 10) and MIG (not shown) in the infected 
gastric mucosa of Bangladeshi volunteers, compared to uninfected mucosa of Swedish or 
Bangladeshi participants (Paper I).  
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Figure 10. Levels of IL-8 (a) and IP-10 (b) protein in biopsy extracts of antral mucosa. Median 
values are indicated by horizontal lines. The open triangle (∇) shows the levels of chemokines in 
one Bangladeshi H. pylori uninfected control individual. (*P<0.05, ***P<0.001; ns: not 
significant). 
  
 Our results also suggest that the levels of IP-10 protein as well as IFN-γ mRNA 
were higher in Bangladeshi compared to Swedish gastric mucosa, which may indicate a 
stronger Th1 response in Bangladeshi individuals. However, the mRNA results need to 
be confirmed in a larger number of participants, including younger Swedish subjects, 
since the Swedish volunteers included in the study so far were considerably older than the 
Bangladeshi participants. Nevertheless, our preliminary analyses of mucosal cytokines 
and chemokines support that both Th1 and Th17 cells contribute to the T-cell responses 
to H. pylori in Bangladeshi adults. 
 
Cytokine responses to H. pylori in PBMCs (Paper IV) 
The results from the mucosal analyses in adults encouraged us to also investigate Th17 
and Th1 responses in Bangladeshi children. However, since it is almost impossible to get 
biopsy material from young children in Bangladesh, we instead analyzed whether T cells 
from young children have a general ability to respond with both IFN-γ and IL-17 
production after stimulation with H. pylori antigens as well as polyclonal stimuli.  
 When PBMCs from individuals of different ages were stimulated with H. pylori 
MP, significantly higher IL-17 responses were observed in cells from infants compared to 
adults (Figure 11). In contrast, the IFN-γ production was comparable in the different 
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study groups. Very low levels of Th2 cytokines (IL-13, IL-4, IL-5) were detected in 
culture supernatants from any of the subjects. In contrast to the MP-induced responses, 
polyclonal PHA stimulation gave rise to significantly lower production of both IL-17 and 
IFN-γ in cells from infants compared to adults, whereas the IL-13 production was slightly 
higher in PBMCs from infants (Figure 11).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Production of IL-17 (black bars), IFN-γ (white bars) and IL-13 (grey bars) from 
PBMCs isolated from infants and adults in response to MP (a) and PHA (b) stimulation. Values 
shown are means + SEM from 12-16 (IL-17, IFN-γ) or 5 (IL-13) individuals. (*P<0.05, **P<0.01). 
 
 Isolated CD4
+
 T cells from infants also responded with lower production of IL-17 
and IFN-γ than CD4+ T cells from adults when stimulated with beads coated with anti-
CD3 and anti-CD28 antibodies in the absence of antigen presenting cells. Bead 
stimulation also induced significantly more IL-5 in infant than adult CD4
+
 T cells and 
there was also a tendency towards more IL-13 production in infant CD4
+
 T cells. 
However, despite these signs of an increased ability to produce Th2 cytokines during 
infancy, the T-cell responses to H. pylori antigens in infants were primarily of the Th17 
and Th1 types. 
 
Analysis of the origin of the cytokine responses in PBMC cultures (Paper IV) 
To determine the origin of the IFN-γ and IL-17 responses observed in response to MP 
stimulation, we analyzed the cytokine responses in PBMCs with and without CD4
+
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both infants and adults and also in reduction of IFN-γ responses in almost all individuals. 
These results suggest that the IL-17 responses observed in the PBMC cultures were 
derived from CD4
+
 T cells, but that other cells, including CD8
+
 T cells and NK cells, may 
contribute to the IFN-γ responses.  
 
Analysis of cytokine responses in relation to infection status (Paper IV) 
For the IL-17 responses, we could not detect any differences between infected and 
uninfected subjects. Similar IFN-γ responses were also observed in cells from infected 
and uninfected infants and children. In contrast, higher IFN-γ responses were observed in 
cultures with PBMCs isolated from infected compared to uninfected adults. The 
responses in uninfected individuals may be a result of previous exposure to H. pylori as 
well as cross reactivity with other bacteria expressing similar antigens. However, further 
studies are needed to explain the different patterns of IL-17 and IFN-γ secretion observed 
in the different study groups. These studies will include analysis of the influence of APC 
derived cytokines for the production of Th1 and Th17 cytokines in infants and adults. 
 Collectively, our results suggest that CD4
+
 T cells can respond with production of 
both Th1 and Th17 type cytokines to H. pylori during childhood as well as adult life. 
Further studies will aim to determine the relative importance of these responses in the 
early stages of H. pylori infection and during chronic infection. 
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GENERAL DISCUSSION 
The incidence of H. pylori infections has decreased substantially in the developed world 
during recent years (42). However, both the incidence and prevalence of such infections 
have been very high and remained stable in many developing countries (42, 73) and in 
certain countries in Eastern Europe (65) during recent decades. This is supported by the 
results of this thesis showing that up to 90% of adult volunteers from Dhaka in 
Bangladesh and/or adults living in an under-privileged area in Mirpur in Dhaka city, were 
positive for H. pylori, both as assessed by a highly specific and sensitive stool antigen 
test (Paper I, IV) and by serology (Paper I, III, IV). Furthermore, a very high incidence, 
approximately 60%, of H. pylori infections was observed in children already during their 
initial two years of life in the Mirpur area using the same stool antigen test and serology 
(Paper II). This finding confirms results from other studies showing that the majority of 
H. pylori infections occur during early childhood (25, 88). 
 Most studies of immune responses to H. pylori have been undertaken in chronically 
infected adults living in developed countries in the world (134). However, very few 
studies have analyzed immune responses to H. pylori infection in highly endemic areas in 
developing countries, or immune responses to acute H. pylori infections. To determine 
how well results from studies in low endemic countries may reflect those from 
individuals living in high endemic areas we undertook a detailed comparison of immune 
responses in Bangladeshi and Swedish H. pylori infected subjects (Paper I). Thus, we 
hypothesized that individuals living in areas with an increased incidence of enteric 
infections and parasitic infestations as well as other confounding factors such as calorie 
and micronutrient deficiencies might respond less well immunologically to H. pylori 
infection (122). However, our analyses showed that mucosal B- as well as T- cell 
responses to H. pylori in the stomach in the Swedish and Bangladeshi H. pylori infected 
individuals were very similar and suggest that findings of mucosal immune responses to 
H. pylori infection in West European and American subjects may be applicable also to 
individuals living in the developing world. Even the numbers of FOXP3
+
 Treg were 
comparable in stomach as well as duodenal mucosa of Bangladeshi and Swedish adults, 
suggesting that the immunological hyporesponsiveness often observed in individuals in 
developing countries may not be a direct result of increased Treg suppression induced by 
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recurrent infections. However, our finding of about 2-fold lower mean serum antibody 
titers to H. pylori in the Bangladeshi than in the Swedish age-matched subjects may be 
important both with regard to a putative protective role of serum antibodies (see below) 
as well as for determining cut off levels for antibody titers signifying seropositivity. 
Thus, cut off levels for seropositivity may differ in different populations and should be 
recognized before use in a certain setting based on comparison with other diagnostic 
tools, e.g. culture, UBT or stool antigen tests (23, 28, 31).  
 Determination of immune responses against acute H. pylori infections may be 
undertaken in human volunteers challenged with virulent H. pylori bacteria. Such studies 
may reveal the kinetics of immune responses at various time points after infection. A few 
such challenge studies have been undertaken (53, 102), but these have been performed in 
adults and not in children who are more likely to acquire H. pylori infection and who may 
respond differently to initial infection compared to adults. Another possibility to study 
immune responses against acute H. pylori infections is to collect clinical samples from 
young children in areas with a high incidence of H. pylori infections and relate 
development of immune responses to onset of infection as determined by e.g. UBT or 
positive stool antigen test. We have chosen the latter approach and collected blood and 
stool samples regularly during the first two years of life from a birth cohort of children 
with a very high incidence of H. pylori infections (Paper II) and determined antibody 
responses in relation to onset of infection (Paper II, III). This has included assessment of 
IgA and IgG antibody responses in serum as well IgA/total IgA rises in stool following 
onset of H. pylori infections during the first two years of life. We have also studied T-cell 
responses in infants and young children in the same setting in H. pylori positive and 
negative children (Paper IV). However, since T-cell responses are more technically 
demanding to analyze than antibody responses, we limited our T-cell studies to children 
with and without H. pylori infection at a given time point and, in contrast to the antibody 
analyses, did not attempt to follow the development of T-cell responses to H. pylori over 
time.  
 We detected at least fourfold rises in IgG and IgA titers to H. pylori in serum in a 
majority of the children during the two year study period. The frequency of seropositive 
children in the birth cohort was also considerably higher than in other studies of immune 
51 
 
responses of H. pylori in young children in developed and developing countries (51). The 
high seropositivity may be due to the unusually high incidence of infections in the birth 
cohort. However, it can also be due to the fact that we used a very sensitive in-house 
ELISA test and assessed end point titers (92), at variance with other studies which have 
utilized commercial ELISA tests which are based on analysis of single dilutions of 
clinical specimens (75, 82). 
 Due to the very high frequency of H. pylori positive adults in Bangladesh, almost 
all the children in the birth cohort had very high IgG titers in serum at birth due to 
transplacentally transferred antibodies from the mothers (Paper III). These titers remained 
for at least 6 months after delivery, making it impossible to determine IgG responses to 
H. pylori infection in serum in the children during their first 6 months of life. Thereafter, 
antibody titers to H. pylori increased with age in relation to onset of infection but also, 
although of significantly lower magnitudes, in stool antigen negative children. IgA titers 
were negligible or very low in all children during the first 3-6 months of life but 
increased thereafter in response to infection, but also to some extent in stool antigen 
negative children. Since we used a whole membrane protein antigen preparation of H. 
pylori bacteria as coating antigen in the ELISA, the titer rises observed in the stool 
antigen negative children may be due to infections with other bacteria expressing cross-
reactive protein antigens. These titer rises may also be explained by infection with low 
levels of H. pylori that could not be detected by the stool antigen test used, or by transient 
infection with H. pylori that could not be detected by our 3 or 6 monthly stool antigen 
analyses (Paper II, III). Our finding of maternal IgG titers in serum during infancy and 
the observation that such titers remained for considerably longer periods than 
corresponding serum IgA titers after spontaneous eradication of infection, support that 
determination of systemic antibody responses to H. pylori in young children should 
preferably be based on IgA antibody analyses. 
 We also explored the possibility of determining mucosal antibody responses to H. 
pylori in stool extracts, using the same approach as we have successfully applied for 
determining mucosal antibody response to oral enteric vaccines (5) (Paper III). However, 
we found that most stool samples had very high IgA titers against H. pylori during the 
first 6 months of life, irrespective of if the children were infected or not. Such anti-H. 
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pylori antibodies in stool probably reflect “contamination” with breast milk antibodies, 
since all children were almost exclusively breastfed during the initial 6 months of life, 
and most mothers had high levels of anti-H. pylori IgA titers in milk during the entire 
lactation period. During the remaining study period between 6 and 24 months, on the 
other hand, specific IgA/total IgA rose at least 4-fold in stool after infection in most 
children, but these responses were considerably more short-lasting than the systemic 
responses (Paper III) as also observed for mucosal immune responses to other enteric 
infections (113, 133). 
 In analogy with a previous study, we found a relatively high incidence of 
spontaneous eradication of H. pylori infection in the young age group of children studied 
(93) (Paper II, III). These spontaneous eradications seem to be related to development of 
specific immune responses against H. pylori infection (Paper III). Thus, we observed 
substantial titer rises both in serum and in stool in relation to onset of the infection in the 
eradicated children; these responses were considerably higher than corresponding 
responses in continuously infected children. However, it is not possible to say whether 
the antibody responses in the eradicated children were protective per se or only reflected 
protection. Studies in different animal models have indicated that Th1 as well as Th17 
immune responses are crucial for protection against H. pylori infection (32, 105, 144), 
but their role in protection from H. pylori infection in humans needs to be further studied. 
Support for a protective role of specific anti-H. pylori antibodies, on the other hand, is 
our findings that children infected with H. pylori during the first year of life had 
significant lower levels of specific IgG antibodies in serum than children who became 
infected during the second year. Furthermore, children who drank milk with low levels of 
anti-H. pylori IgA antibodies were infected with H. pylori considerably earlier than 
children fed breast milk with higher levels of specific IgA titers (Paper III). A relation 
between specific breast milk antibody titers against urease and protection against 
colonization by H. pylori has been observed in Gambian infants (138). Furthermore, a 
recent meta-analysis has supported that breast feeding is protective against H. pylori 
infection, with an effect primarily seen in studies in LMIC (24).  
 In addition to a protective role of specific antibodies against acute H. pylori 
infection during early childhood, our results suggest that Th17 as well as Th1 type T- cell 
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responses may contribute to effective immune responses against H. pylori (Paper IV). 
Thus, we observed that CD4
+
 T cells from infants were able to produce relatively high 
levels of both IL-17 and IFN-γ in response to stimulation with H. pylori antigens. These 
findings are interesting in relation to the recent demonstration of the importance of IL-17 
producing cells for the recruitment of neutrophils to the gastric mucosa in immunized and 
challenged mice (32). In immunized mice, neutrophil depletion resulted in increased 
bacterial colonization of the gastric mucosa after challenge (32), suggesting that Th17 
cells can play a role in limiting the infection. Interestingly, several recent studies also 
suggest that Th17 cells can promote B-cell survival and differentiation (33), enhance B-
cell recruitment to mucosal sites (62) and increase the expression of the polymeric 
immunoglobulin receptor on epithelial cells, thereby elevating secretory IgA levels in 
mucosal secretions (63). However, whether both antibodies and Th17 cells may 
contribute to the delayed onset and spontaneous eradication of H. pylori infection 
observed in children in the birth cohort remains to be further investigated.  
 In this thesis, we have also evaluated different socioeconomic factors that may 
predispose to H. pylori infection during early childhood (Paper II). In accordance with 
several other studies we confirm that low maternal (12, 88), and in this thesis also low 
paternal education level (Paper II) were associated with increased susceptibility to H. 
pylori infection in the birth cohort in Mirpur. However, other socioeconomic factors such 
as access to clean water, latrines, family crowding etc did not relate to incidence of 
infection. Interestingly, we observed a clear seasonality with regard to onset of infection 
that seemed to relate to peak seasons for bacterial enteric infections (Paper I). To our 
knowledge, such a seasonality of H. pylori infections has not been observed previously. 
The seasonality may be explained by our recent finding of high numbers of 
transcriptionally active H. pylori bacteria in vomitus from individuals with diarrhoeal 
diseases (66). Thus, in crowded areas with poor hygiene vomiting caused by 
gastrointestinal infections may promote the transmission of H. pylori. We also found that 
children with blood group “A” had a significantly increased susceptibility to H. pylori 
infection compared to children with other blood groups, which is at variance with another 
report in which no relation between ABO blood group and susceptibility to H. pylori 
infection was observed (120). A similar relationship between blood group “A” and ETEC 
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infection was observed in the same birth cohort as studied in this thesis (112). The reason 
for this increased susceptibility in blood group “A” children to two such different 
mucosal pathogens is unclear at present, but will be explored in future studies of binding 
structures of H. pylori and ETEC colonizing factors (64). 
 In conclusion, this thesis describes a number of different factors that may promote 
as well as prevent H. pylori infection during early childhood. Our findings may play a 
role in the development of effective preventive and treatment strategies that should be 
particularly important for those who are at highest risk of being infected with H. pylori, 
e.g. children in high endemic countries, especially children in the developing world that 
have less opportunities for conventional antibiotic therapy regimens (4, 134).  
55 
 
ACKNOWLEDGEMENTS 
 
First of all, I would like to thank Almighty Allah, the most gracious and merciful for 
allowing me the opportunity for making this PhD study possible. This thesis arose as a result 
of collaboration between ICDDR,B and the University of Gothenburg.  
 
I would like to express my sincere gratitude to my main supervisor, Anna Lundgren, at the 
University of Gothenburg, for excellent supervision, advice, teaching and guidance from the 
very beginning of this project as well as giving me extraordinary experiences throughout the 
work. Thank you for your stimulating brain storming session, persistent encouragement and 
intense discussion aiming to increase my knowledge of the field and to think more carefully. 
During the thesis-writing period, your continuous encouragement helped me lot. I am also 
very grateful for the full support and trust you put in me during this journey. 
 
Ann-Mari Svennerholm, my co-supervisor at the University of Gothenburg, Sweden. 
Without your enthusiasm, inspiration, teaching, support and great efforts to explain things 
clearly and simply, my project would not have been accomplishable. The analyses that we 
did for the birth cohort study; they were unbelievably many. But we did them and it would 
not have been possible without your active, hard and excellent efforts. Thanks also for taking 
care of me in a nice way during my stays in Gothenburg.  
 
Firdausi Qadri, my co-supervisor at ICDDR,B in Dhaka Bangladesh. Apa, it is my 
immense pleasure to convey my gratitude and respect to you. Your deep and generous 
involvement in scientific research has boosted me to think intellectually. I gratefully 
acknowledge you for introducing me to Ann-Mari and to arrange this collaboration program. 
Your enthusiasm, diligent manner, sincerity and dynamic approach inspired me to think 
diversely. Thank you so much for giving me opportunity to think individually as well as for 
your continuous support, openness to new ideas, optimism, and patience to listen to what I 
am doing and for constructive feedback. I am really grateful to you.  
 
I convey my special acknowledgements to Alejandro Cravioto, Executive Director of 
ICDDR,B and Jan Holmgren, former chairman of the Department of Microbiology and 
Immunology, University of Gothenburg, for their help for approving PhD funds and for 
accepting me as a PhD student of the department, respectively. 
 
Bert Kindlund and Anders Janzon, I acknowledge and thank you for your help as a 
coauthors in different manuscripts.  
 
I gratefully thank Hubert P Endtz, Yasmin A Begum, Tanvir Ahmed, Mohiul I 
Chowdhury, Fahima Chowdhury, Amit Saha, Prodip K Bardhan, Mian M Ahmad, for 
your vital support at different phases of the study in Mirpur, ICDDR,B or the Dhaka Medical 
College Hospital. The recruitment and clinical assessment of participants and performing of 
endoscopies and the microbiological and clinical evaluations would not have been possible 
without your support. I would also like to thank all the field staff and study participants who 
were involved in this research.  
 
Sukanya Raghavan, thanks for critically reading manuscript IV and for understanding the 
similarities and differences between studies in mice versus humans. 
56 
 
My special thanks to Alaullah Sheikh, Saruar Bhuiyan, Alison Kuschta for constructive 
criticism during my experimental work and during thesis writing. I would like to give big 
thanks to Prodip Chandra Das and Fatema Khatoon for helping me actively at ICDDR,B. 
Delower Hossain, Momotaz Khanum and Shahnaz Begum helped me lot when I was 
overworked in sorting the right set of samples for the analyses. I would also like to thank 
Joanna Kaim at the University of Gothenburg, for helping me to do CBA and ELISAs when 
I was running out of time. It was a great help for me. 
 
I would like to acknowledge and thank my colleagues Samuel Lundin, Asa Sjoling, 
Matilda Nicklasson, Joshua Tobias, Marianne Quiding, Ingrid Bolin and Lena Ekman 
for giving me such a pleasant time when working together and in the lunch room at the 
University of Gothenburg. 
 
Many thanks also to my colleagues in Gothenburg for providing a nice environment for 
working but also a place in which I had fun and found entertainment. I am especially grateful 
to Patrik Sundstrom, Erik Nygren, Claudia Rodas, Asa Lothigius, Asa Lindgren, 
Veronica Olofsson, Susannah Leach and Lucia Gonzales.  
 
I gratefully thank Faozul Kabir, Abu Jaher, Susanne Uhlan, Harald Estling, Andrea 
Frateschi, Annika Djarf, Tinna Carlsson and Gudrun Wiklund for their valuable help 
dealing with travel arrangement, office supplies, shipments and different logistic problems 
during my stays in Dhaka and Gothenburg.  
 
I am remembering my father, Md Zahidur Rahman Bhuiyan who encouraged me to study 
and seek knowledge. Heartfelt thanks to my mother Hoshne ara-Zahid, you played a pivotal 
role for where I am today as you alone became responsible for my upbringing when my 
father passed away. Thanks also to Mahabubur Rahman and Nasima Khanam, my father 
in-law and mother in-law, for your excellent support, smiling faces and care that gave me 
courage to work without worrying about anything. You were in anxiety how I could survive 
in Gothenburg without knowing any cooking, but I did survive! Thanks to my brothers, 
Leeon and Shovon, for your nice mails while I was away from home. Rajib, my brother in-
law, I will never forget how you managed to communicate with me everyday while I was 
away. I realize how difficult it was for you while you were also away from home. But you 
made it. Many thanks. Thanks to all other extended family members for taking care of my 
family in my absence during my PhD project.  
 
Finally, Ema, without your continuous support at every moment and tremendous and 
extreme patience I never would have made it to the end. I cannot express what you mean to 
me. Tamjid, does not always understand everything, but your smiling face, good health, 
peculiar queries and joy has given me the energy to work.  
 
 
 
 
This research was supported by the Swedish Agency for Research and Economic 
Cooperation (SAREC), the Swedish Research Council for Medicine and the Marianne and 
Markus Wallenberg Foundation through the support to GUVAX, The Sahlgrenska Academy 
(LUA/ALF) and ICDDR, B. 
57 
 
REFERENCES 
 
1. Achtman, M., M. Schwuchnow, R. Helmuth, S. Morelli, and P. A. Manning. 1978. Cell-
cell interactions in conjugating E. coli: conmutants and stabilization of mating 
aggregates. Mol Gen Genet 164:171-183. 
2. Aebischer, T., S. Laforsch, R. Hurwitz, F. Brombacher, and T. F. Meyer. 2001. Immunity 
against Helicobacter pylori: significance of interleukin-4 receptor alpha chain status and 
gender of infected mice. Infection and immunity 69:556-558. 
3. Ahlstedt, I., C. Lindholm, H. Lonroth, A. Hamlet, A. M. Svennerholm, and M. Quiding-
Jarbrink. 1999. Role of local cytokines in increased gastric expression of the secretory 
component in Helicobacter pylori infection. Infection and immunity 67:4921-4925. 
4. Ahmed, S., M. Salih, W. Jafri, H. Ali Shah, and S. Hamid. 2009. Helicobacter pylori 
infection: approach of primary care physicians in a developing country. BMC 
Gastroenterol 9:23. 
5. Ahren, C., M. Jertborn, and A. M. Svennerholm. 1998. Intestinal immune responses to an 
inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin 
A responses in blood. Infection and immunity 66:3311-3316. 
6. Akhiani, A. A., J. Pappo, Z. Kabok, K. Schon, W. Gao, L. E. Franzen, and N. Lycke. 
2002. Protection against Helicobacter pylori infection following immunization is IL-12-
dependent and mediated by Th1 cells. J Immunol 169:6977-6984. 
7. Akhiani, A. A., K. Schon, and N. Lycke. 2004. Vaccine-induced immunity against 
Helicobacter pylori infection is impaired in IL-18-deficient mice. J Immunol 173:3348-
3356. 
8. Andersen, L. P., S. Holck, D. Janulaityte-Gunther, L. Kupcinskas, G. Kiudelis, L. 
Jonaitis, D. Janciauskas, P. Holck, M. Bennedsen, H. Permin, S. Norn, and T. Wadstrom. 
2005. Gastric inflammatory markers and interleukins in patients with functional 
dyspepsia, with and without Helicobacter pylori infection. FEMS immunology and 
medical microbiology 44:233-238. 
9. Appelmelk, B. J., Y. Q. An, M. Geerts, B. G. Thijs, H. A. de Boer, D. M. MacLaren, J. de 
Graaff, and J. H. Nuijens. 1994. Lactoferrin is a lipid A-binding protein. Infection and 
immunity 62:2628-2632. 
10. Atherton, J. C., K. T. Tham, R. M. Peek, Jr., T. L. Cover, and M. J. Blaser. 1996. Density 
of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. 
The Journal of infectious diseases 174:552-556. 
11. Bamford, K. B., X. Fan, S. E. Crowe, J. F. Leary, W. K. Gourley, G. K. Luthra, E. G. 
Brooks, D. Y. Graham, V. E. Reyes, and P. B. Ernst. 1998. Lymphocytes in the human 
gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. 
Gastroenterology 114:482-492. 
12. Bassily, S., R. W. Frenck, E. W. Mohareb, T. Wierzba, S. Savarino, E. Hall, A. Kotkat, 
A. Naficy, K. C. Hyams, and J. Clemens. 1999. Seroprevalence of Helicobacter pylori 
among Egyptian newborns and their mothers: a preliminary report. The American journal 
of tropical medicine and hygiene 61:37-40. 
13. Bedoya, A., J. Garay, F. Sanzon, L. E. Bravo, J. C. Bravo, H. Correa, R. Craver, E. 
Fontham, J. X. Du, and P. Correa. 2003. Histopathology of gastritis in Helicobacter 
pylori-infected children from populations at high and low gastric cancer risk. Human 
pathology 34:206-213. 
14. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of host-
microorganism interactions. Annual review of immunology 27:551-589. 
15. Bergquist, C., A. Mattsson-Rydberg, H. Lonroth, and A. Svennerholm. 2000. 
Development of a new method for the determination of immune responses in the human 
stomach. Journal of immunological methods 234:51-59. 
58 
 
16. Birkholz, S., U. Knipp, and W. Opferkuch. 1993. Stimulatory effects of Helicobacter 
pylori on human peripheral blood mononuclear cells of H. pylori infected patients and 
healthy blood donors. Zentralbl Bakteriol 280:166-176. 
17. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. 
N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains 
possessing cagA is associated with an increased risk of developing adenocarcinoma of 
the stomach. Cancer research 55:2111-2115. 
18. Bode, G., I. Piechotowski, D. Rothenbacher, and H. Brenner. 2002. Helicobacter pylori-
specific immune responses of children: implications for future vaccination strategy. 
Clinical and diagnostic laboratory immunology 9:1126-1128. 
19. Bogstedt, A. K., S. Nava, T. Wadstrom, and L. Hammarstrom. 1996. Helicobacter pylori 
infections in IgA deficiency: lack of role for the secretory immune system. Clinical and 
experimental immunology 105:202-204. 
20. Bontems, P., F. Robert, A. Van Gossum, S. Cadranel, and F. Mascart. 2003. Helicobacter 
pylori modulation of gastric and duodenal mucosal T cell cytokine secretions in children 
compared with adults. Helicobacter 8:216-226. 
21. Caruso, R., D. Fina, O. A. Paoluzi, G. Del Vecchio Blanco, C. Stolfi, A. Rizzo, F. 
Caprioli, M. Sarra, F. Andrei, M. C. Fantini, T. T. MacDonald, F. Pallone, and G. 
Monteleone. 2008. IL-23-mediated regulation of IL-17 production in Helicobacter 
pylori-infected gastric mucosa. European journal of immunology 38:470-478. 
22. Caruso, R., F. Pallone, and G. Monteleone. 2007. Emerging role of IL-23/IL-17 axis in 
H. pylori-associated pathology. World J Gastroenterol 13:5547-5551. 
23. Casswall, T. H., H. O. Nilsson, M. Bergstrom, P. Aleljung, T. Wadstrom, A. K. 
Dahlstrom, M. J. Albert, and S. A. Sarker. 1999. Evaluation of serology, 13C-urea breath 
test, and polymerase chain reaction of stool samples to detect Helicobacter pylori in 
Bangladeshi children. Journal of pediatric gastroenterology and nutrition 28:31-36. 
24. Chak, E., G. W. Rutherford, and C. Steinmaus. 2009. The role of breast-feeding in the 
prevention of Helicobacter pylori infection: a systematic review. Clin Infect Dis 48:430-
437. 
25. Clemens, J., M. J. Albert, M. Rao, S. Huda, F. Qadri, F. P. Van Loon, B. Pradhan, A. 
Naficy, and A. Banik. 1996. Sociodemographic, hygienic and nutritional correlates of 
Helicobacter pylori infection of young Bangladeshi children. The Pediatric infectious 
disease journal 15:1113-1118. 
26. Clyne, M., J. Thomas, L. Weaver, and B. Drumm. 1997. In vitro evaluation of the role of 
antibodies against Helicobacter pylori in inhibiting adherence of the organism to gastric 
cells. Gut 40:731-738. 
27. Cover, T. L. 1996. The vacuolating cytotoxin of Helicobacter pylori. Molecular 
microbiology 20:241-246. 
28. Czinn, S. J. 1999. Serodiagnosis of Helicobacter pylori in pediatric patients. Journal of 
pediatric gastroenterology and nutrition 28:132-134. 
29. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection 
by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11:637-642. 
30. D'Elios, M. M., M. Manghetti, F. Almerigogna, A. Amedei, F. Costa, D. Burroni, C. T. 
Baldari, S. Romagnani, J. L. Telford, and G. Del Prete. 1997. Different cytokine profile 
and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the 
antrum of chronic gastritis patients with or without peptic ulcer. European journal of 
immunology 27:1751-1755. 
31. de Oliveira, A. M., G. A. Rocha, D. M. Queiroz, E. N. Mendes, A. S. de Carvalho, T. C. 
Ferrari, and A. M. Nogueira. 1999. Evaluation of enzyme-linked immunosorbent assay 
for the diagnosis of Helicobacter pylori infection in children from different age groups 
59 
 
with and without duodenal ulcer. Journal of pediatric gastroenterology and nutrition 
28:157-161. 
32. DeLyria, E. S., R. W. Redline, and T. G. Blanchard. 2009. Vaccination of mice against H 
pylori induces a strong Th-17 response and immunity that is neutrophil dependent. 
Gastroenterology 136:247-256. 
33. Doreau, A., A. Belot, J. Bastid, B. Riche, M. C. Trescol-Biemont, B. Ranchin, N. Fabien, 
P. Cochat, C. Pouteil-Noble, P. Trolliet, I. Durieu, J. Tebib, B. Kassai, S. Ansieau, A. 
Puisieux, J. F. Eliaou, and N. Bonnefoy-Berard. 2009. Interleukin 17 acts in synergy with 
B cell-activating factor to influence B cell biology and the pathophysiology of systemic 
lupus erythematosus. Nature immunology 10:778-785. 
34. Dowsett, S. A., and M. J. Kowolik. 2003. Oral Helicobacter pylori: can we stomach it? 
Crit Rev Oral Biol Med 14:226-233. 
35. Drumm, B., S. Koletzko, and G. Oderda. 2000. Helicobacter pylori infection in children: 
a consensus statement. European Paediatric Task Force on Helicobacter pylori. Journal 
of pediatric gastroenterology and nutrition 30:207-213. 
36. Eaton, K. A., M. Mefford, and T. Thevenot. 2001. The role of T cell subsets and 
cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 
166:7456-7461. 
37. Enarsson, K., A. Lundgren, B. Kindlund, M. Hermansson, G. Roncador, A. H. Banham, 
B. S. Lundin, and M. Quiding-Jarbrink. 2006. Function and recruitment of mucosal 
regulatory T cells in human chronic Helicobacter pylori infection and gastric 
adenocarcinoma. Clinical immunology 121:358-368. 
38. Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, 
H. Kleanthous, and T. P. Monath. 1998. Immunization of mice with urease vaccine 
affords protection against Helicobacter pylori infection in the absence of antibodies and 
is mediated by MHC class II-restricted responses. The Journal of experimental medicine 
188:2277-2288. 
39. Ernst, P. B., and B. D. Gold. 2000. The disease spectrum of Helicobacter pylori: the 
immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annual review of 
microbiology 54:615-640. 
40. Fiedorek, S. C., H. M. Malaty, D. L. Evans, C. L. Pumphrey, H. B. Casteel, D. J. Evans, 
Jr., and D. Y. Graham. 1991. Factors influencing the epidemiology of Helicobacter pylori 
infection in children. Pediatrics 88:578-582. 
41. Filipovich, A. H., A. Mathur, D. Kamat, J. H. Kersey, and R. S. Shapiro. 1994. 
Lymphoproliferative disorders and other tumors complicating immunodeficiencies. 
Immunodeficiency 5:91-112. 
42. Frenck, R. W., Jr., and J. Clemens. 2003. Helicobacter in the developing world. Microbes 
and infection 5:705-713. 
43. Garhart, C. A., F. P. Heinzel, S. J. Czinn, and J. G. Nedrud. 2003. Vaccine-induced 
reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but 
gamma interferon and inducible nitric oxide synthase independent. Infection and 
immunity 71:910-921. 
44. Gebert, B., W. Fischer, E. Weiss, R. Hoffmann, and R. Haas. 2003. Helicobacter pylori 
vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102. 
45. Genta, R. M., H. W. Hamner, and D. Y. Graham. 1993. Gastric lymphoid follicles in 
Helicobacter pylori infection: frequency, distribution, and response to triple therapy. 
Human pathology 24:577-583. 
46. Gerhard, M., N. Lehn, N. Neumayer, T. Boren, R. Rad, W. Schepp, S. Miehlke, M. 
Classen, and C. Prinz. 1999. Clinical relevance of the Helicobacter pylori gene for blood-
group antigen-binding adhesin. Proceedings of the National Academy of Sciences of the 
United States of America 96:12778-12783. 
60 
 
47. Gisbert, J. P., M. Trapero, and J. M. Pajares. 2005. Evaluation of 3 different tests for the 
detection of stool antigens to confirm Helicobacter pylori eradication after treatment. A 
pilot study. Gastroenterologia y hepatologia 28:615-618. 
48. Glass, R. I., J. Holmgren, C. E. Haley, M. R. Khan, A. M. Svennerholm, B. J. Stoll, K. 
M. Belayet Hossain, R. E. Black, M. Yunus, and D. Barua. 1985. Predisposition for 
cholera of individuals with O blood group. Possible evolutionary significance. American 
journal of epidemiology 121:791-796. 
49. Gosciniak, G. 1997. IgG and IgA antibodies in Helicobacter pylori infections. Zentralbl 
Bakteriol 286:494-502. 
50. Gottrand, F., F. Cullu, D. Turck, P. Vincent, L. Michaud, M. O. Husson, E. Martin-
Delasalle, and J. P. Farriaux. 1997. Normal gastric histology in Helicobacter pylori-
infected children. Journal of pediatric gastroenterology and nutrition 25:74-78. 
51. Graham, D. Y., E. Adam, G. T. Reddy, J. P. Agarwal, R. Agarwal, D. J. Evans, Jr., H. M. 
Malaty, and D. G. Evans. 1991. Seroepidemiology of Helicobacter pylori infection in 
India. Comparison of developing and developed countries. Digestive diseases and 
sciences 36:1084-1088. 
52. Graham, D. Y., H. Lu, and Y. Yamaoka. 2009. African, Asian or Indian enigma, the East 
Asian Helicobacter pylori: facts or medical myths. Journal of digestive diseases 10:77-
84. 
53. Graham, D. Y., A. R. Opekun, M. S. Osato, H. M. El-Zimaity, C. K. Lee, Y. Yamaoka, 
W. A. Qureshi, M. Cadoz, and T. P. Monath. 2004. Challenge model for Helicobacter 
pylori infection in human volunteers. Gut 53:1235-1243. 
54. Granstrom, M., Y. Tindberg, and M. Blennow. 1997. Seroepidemiology of Helicobacter 
pylori infection in a cohort of children monitored from 6 months to 11 years of age. 
Journal of clinical microbiology 35:468-470. 
55. Hamid, Q., and M. Tulic. 2009. Immunobiology of asthma. Annual review of physiology 
71:489-507. 
56. Hamlet, A., A. C. Thoreson, O. Nilsson, A. M. Svennerholm, and L. Olbe. 1999. 
Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic 
subjects and patients with duodenal ulcers. Gastroenterology 116:259-268. 
57. Harris, J. B., A. I. Khan, R. C. LaRocque, D. J. Dorer, F. Chowdhury, A. S. Faruque, D. 
A. Sack, E. T. Ryan, F. Qadri, and S. B. Calderwood. 2005. Blood group, immunity, and 
risk of infection with Vibrio cholerae in an area of endemicity. Infection and immunity 
73:7422-7427. 
58. Harris, P. R., S. W. Wright, C. Serrano, F. Riera, I. Duarte, J. Torres, A. Pena, A. Rollan, 
P. Viviani, E. Guiraldes, J. M. Schmitz, R. G. Lorenz, L. Novak, L. E. Smythies, and P. 
D. Smith. 2008. Helicobacter pylori gastritis in children is associated with a regulatory T-
cell response. Gastroenterology 134:491-499. 
59. Holcombe, C., S. Tsimiri, J. Eldridge, and D. M. Jones. 1993. Prevalence of antibody to 
Helicobacter pylori in children in northern Nigeria. Transactions of the Royal Society of 
Tropical Medicine and Hygiene 87:19-21. 
60. Ilver, D., A. Arnqvist, J. Ogren, I. M. Frick, D. Kersulyte, E. T. Incecik, D. E. Berg, A. 
Covacci, L. Engstrand, and T. Boren. 1998. Helicobacter pylori adhesin binding 
fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377. 
61. Infante-Duarte, C., H. F. Horton, M. C. Byrne, and T. Kamradt. 2000. Microbial 
lipopeptides induce the production of IL-17 in Th cells. J Immunol 165:6107-6115. 
62. Jaffar, Z., M. E. Ferrini, T. A. Girtsman, and K. Roberts. 2009. Antigen-specific Treg 
regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and 
polymeric IgA and IgM levels in the airways. European journal of immunology 39:3307-
3314. 
61 
 
63. Jaffar, Z., M. E. Ferrini, L. A. Herritt, and K. Roberts. 2009. Cutting edge: Lung mucosal 
Th17-mediated responses induce polymeric Ig receptor expression by the airway 
epithelium and elevate secretory IgA levels. J Immunol 182:4507-4511. 
64. Jansson, L., J. Tobias, M. Lebens, A. M. Svennerholm, and S. Teneberg. 2006. The major 
subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a 
glycosphingolipid binding protein. Infection and immunity 74:3488-3497. 
65. Janulaityte-Gunther, D., R. Kucinskiene, L. Kupcinskas, A. Pavilonis, L. Labanauskas, 
A. Cizauskas, U. Schmidt, T. Wadstrom, and L. P. Andersen. 2005. The humoral 
immuneresponse to Helicobacter pylori infection in children with gastrointestinal 
symptoms. FEMS immunology and medical microbiology 44:205-212. 
66. Janzon, A., T. Bhuiyan, A. Lundgren, F. Qadri, A. M. Svennerholm, and A. Sjoling. 
2009. Presence of high numbers of transcriptionally active Helicobacter pylori in vomitus 
from Bangladeshi patients suffering from acute gastroenteritis. Helicobacter 14:237-247. 
67. Karttunen, R., G. Andersson, K. Poikonen, T. U. Kosunen, T. Karttunen, K. Juutinen, and 
S. Niemela. 1990. Helicobacter pylori induces lymphocyte activation in peripheral blood 
cultures. Clinical and experimental immunology 82:485-488. 
68. Khader, S. A., G. K. Bell, J. E. Pearl, J. J. Fountain, J. Rangel-Moreno, G. E. Cilley, F. 
Shen, S. M. Eaton, S. L. Gaffen, S. L. Swain, R. M. Locksley, L. Haynes, T. D. Randall, 
and A. M. Cooper. 2007. IL-23 and IL-17 in the establishment of protective pulmonary 
CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis 
challenge. Nature immunology 8:369-377. 
69. Kindermann, A., H. Demmelmair, B. Koletzko, S. Krauss-Etschmann, B. Wiebecke, and 
S. Koletzko. 2000. Influence of age on 13C-urea breath test results in children. Journal of 
pediatric gastroenterology and nutrition 30:85-91. 
70. Kivi, M., and Y. Tindberg. 2006. Helicobacter pylori occurrence and transmission: a 
family affair? Scandinavian journal of infectious diseases 38:407-417. 
71. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka, and V. K. 
Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 
cells. Nature 448:484-487. 
72. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annual 
review of immunology 27:485-517. 
73. Kusters, J. G., A. H. van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter 
pylori infection. Clinical microbiology reviews 19:449-490. 
74. Lacotte, S., S. Brun, S. Muller, and H. Dumortier. 2009. CXCR3, inflammation, and 
autoimmune diseases. Annals of the New York Academy of Sciences 1173:310-317. 
75. Laheij, R. J., H. Straatman, J. B. Jansen, and A. L. Verbeek. 1998. Evaluation of 
commercially available Helicobacter pylori serology kits: a review. Journal of clinical 
microbiology 36:2803-2809. 
76. Laporte, R., P. Pernes, P. Pronnier, F. Gottrand, and P. Vincent. 2004. Acquisition of 
Helicobacter pylori infection after outbreaks of gastroenteritis: prospective cohort survey 
in institutionalised young people. BMJ 329:204-205. 
77. Laurence, A., and J. J. O'Shea. 2007. T(H)-17 differentiation: of mice and men. Nature 
immunology 8:903-905. 
78. Leal-Herrera, Y., J. Torres, T. P. Monath, I. Ramos, A. Gomez, A. Madrazo-de la Garza, 
M. Dehesa-Violante, and O. Munoz. 2003. High rates of recurrence and of transient 
reinfections of Helicobacter pylori in a population with high prevalence of infection. The 
American journal of gastroenterology 98:2395-2402. 
79. Leung, W. K., K. L. Siu, C. K. Kwok, S. Y. Chan, R. Sung, and J. J. Sung. 1999. 
Isolation of Helicobacter pylori from vomitus in children and its implication in gastro-
oral transmission. The American journal of gastroenterology 94:2881-2884. 
62 
 
80. Lindholm, C., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet, and A. M. Svennerholm. 
1998. Local cytokine response in Helicobacter pylori-infected subjects. Infection and 
immunity 66:5964-5971. 
81. Lindkvist, P., D. Asrat, I. Nilsson, E. Tsega, G. L. Olsson, B. Wretlind, and J. Giesecke. 
1996. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low 
prevalence country. Scandinavian journal of infectious diseases 28:181-184. 
82. Loy, C. T., L. M. Irwig, P. H. Katelaris, and N. J. Talley. 1996. Do commercial 
serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. The 
American journal of gastroenterology 91:1138-1144. 
83. Lundgren, A., E. Stromberg, A. Sjoling, C. Lindholm, K. Enarsson, A. Edebo, E. 
Johnsson, E. Suri-Payer, P. Larsson, A. Rudin, A. M. Svennerholm, and B. S. Lundin. 
2005. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter 
pylori-infected patients. Infection and immunity 73:523-531. 
84. Lundgren, A., C. Trollmo, A. Edebo, A. M. Svennerholm, and B. S. Lundin. 2005. 
Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human 
Helicobacter pylori-infected gastric mucosa. Infection and immunity 73:5612-5619. 
85. Luzza, F., T. Parrello, G. Monteleone, L. Sebkova, M. Romano, R. Zarrilli, M. Imeneo, 
and F. Pallone. 2000. Up-regulation of IL-17 is associated with bioactive IL-8 expression 
in Helicobacter pylori-infected human gastric mucosa. J Immunol 165:5332-5337. 
86. Luzza, F., T. Parrello, L. Sebkova, L. Pensabene, M. Imeneo, M. Mancuso, A. M. La 
Vecchia, G. Monteleone, P. Strisciuglio, and F. Pallone. 2001. Expression of 
proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of 
Helicobacter pylori infected children. Dig Liver Dis 33:14-20. 
87. Magista, A. M., E. Ierardi, S. Castellaneta, V. L. Miniello, E. Lionetti, A. Francavilla, P. 
Ros, N. Rigillo, A. Di Leo, and R. Francavilla. 2005. Helicobacter pylori status and 
symptom assessment two years after eradication in pediatric patients from a high 
prevalence area. Journal of pediatric gastroenterology and nutrition 40:312-318. 
88. Mahalanabis, D., M. M. Rahman, S. A. Sarker, P. K. Bardhan, P. Hildebrand, C. 
Beglinger, and K. Gyr. 1996. Helicobacter pylori infection in the young in Bangladesh: 
prevalence, socioeconomic and nutritional aspects. International journal of epidemiology 
25:894-898. 
89. Mahdavi, J., B. Sonden, M. Hurtig, F. O. Olfat, L. Forsberg, N. Roche, J. Angstrom, T. 
Larsson, S. Teneberg, K. A. Karlsson, S. Altraja, T. Wadstrom, D. Kersulyte, D. E. Berg, 
A. Dubois, C. Petersson, K. E. Magnusson, T. Norberg, F. Lindh, B. B. Lundskog, A. 
Arnqvist, L. Hammarstrom, and T. Boren. 2002. Helicobacter pylori SabA adhesin in 
persistent infection and chronic inflammation. Science 297:573-578. 
90. Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of 
patients with gastritis and peptic ulceration. Lancet 1:1311-1315. 
91. Mattsson, A., M. Quiding-Jarbrink, H. Lonroth, A. Hamlet, I. Ahlstedt, and A. 
Svennerholm. 1998. Antibody-secreting cells in the stomachs of symptomatic and 
asymptomatic Helicobacter pylori-infected subjects. Infection and immunity 66:2705-
2712. 
92. Mattsson, A., A. Tinnert, A. Hamlet, H. Lonroth, I. Bolin, and A. M. Svennerholm. 1998. 
Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic 
Helicobacter pylori-infected subjects. Clinical and diagnostic laboratory immunology 
5:288-293. 
93. Miranda, A. C., R. S. Machado, and E. Kawakami. 2008. Spontaneous elimination of 
Helicobacter pylori infection in a cohort of asymptomatic school children by enzyme-
linked immunosorbent assay polyclonal antigen in stool. Journal of clinical 
gastroenterology 42:143-146. 
63 
 
94. Mitchell, H. M., Y. Y. Li, P. J. Hu, Q. Liu, M. Chen, G. G. Du, Z. J. Wang, A. Lee, and 
S. L. Hazell. 1992. Epidemiology of Helicobacter pylori in southern China: identification 
of early childhood as the critical period for acquisition. The Journal of infectious diseases 
166:149-153. 
95. Mizuno, T., T. Ando, K. Nobata, T. Tsuzuki, O. Maeda, O. Watanabe, M. Minami, K. 
Ina, K. Kusugami, R. M. Peek, and H. Goto. 2005. Interleukin-17 levels in Helicobacter 
pylori-infected gastric mucosa and pathologic sequelae of colonization. World J 
Gastroenterol 11:6305-6311. 
96. Mohammadi, M., J. Nedrud, R. Redline, N. Lycke, and S. J. Czinn. 1997. Murine CD4 T-
cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce 
bacterial load. Gastroenterology 113:1848-1857. 
97. Moujaber, T., C. R. MacIntyre, J. Backhouse, H. Gidding, H. Quinn, and G. L. Gilbert. 
2008. The seroepidemiology of Helicobacter pylori infection in Australia. Int J Infect Dis 
12:500-504. 
98. Nahar, S., A. K. Mukhopadhyay, R. Khan, M. M. Ahmad, S. Datta, S. Chattopadhyay, S. 
C. Dhar, S. A. Sarker, L. Engstrand, D. E. Berg, G. B. Nair, and M. Rahman. 2004. 
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. Journal 
of clinical microbiology 42:4856-4858. 
99. Nakamura, K., A. Kitani, and W. Strober. 2001. Cell contact-dependent 
immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-
bound transforming growth factor beta. The Journal of experimental medicine 194:629-
644. 
100. Nares-Cisneros, J., Y. Jaramillo-Rodriguez, V. A. Martinez-Ordaz, V. M. Velasco-
Rodriguez, A. Madero, G. Mena-Arias, and L. Manriquez-Covarrubias. 2007. 
Immunochromatographic monoclonal test for detection of Helicobacter pylori antigen in 
stool is useful in children from high-prevalence developing country. Helicobacter 12:354-
358. 
101. Nessa, J., H. Chart, R. J. Owen, and B. Drasar. 2001. Human serum antibody response to 
Helicobacter pylori whole cell antigen in an institutionalized Bangladeshi population. 
Journal of applied microbiology 90:68-72. 
102. Nurgalieva, Z. Z., M. E. Conner, A. R. Opekun, C. Q. Zheng, S. N. Elliott, P. B. Ernst, 
M. Osato, M. K. Estes, and D. Y. Graham. 2005. B-cell and T-cell immune responses to 
experimental Helicobacter pylori infection in humans. Infection and immunity 73:2999-
3006. 
103. Nystrom, J., S. Raghavan, and A. M. Svennerholm. 2006. Mucosal immune responses are 
related to reduction of bacterial colonization in the stomach after therapeutic 
Helicobacter pylori immunization in mice. Microbes and infection 8:442-449. 
104. Nystrom, J., and A. M. Svennerholm. 2007. Oral immunization with HpaA affords 
therapeutic protective immunity against H. pylori that is reflected by specific mucosal 
immune responses. Vaccine 25:2591-2598. 
105. O'Keeffe, J., and A. P. Moran. 2008. Conventional, regulatory, and unconventional T 
cells in the immunologic response to Helicobacter pylori. Helicobacter 13:1-19. 
106. O'Rourke, K., K. J. Goodman, M. Grazioplene, T. Redlinger, and R. S. Day. 2003. 
Determinants of geographic variation in Helicobacter pylori infection among children on 
the US-Mexico border. American journal of epidemiology 158:816-824. 
107. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. 
Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. 
Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. 
Hannum, J. F. Bazan, and R. A. Kastelein. 2000. Novel p19 protein engages IL-12p40 to 
form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. 
Immunity 13:715-725. 
64 
 
108. Pappo, J., D. Torrey, L. Castriotta, A. Savinainen, Z. Kabok, and A. Ibraghimov. 1999. 
Helicobacter pylori infection in immunized mice lacking major histocompatibility 
complex class I and class II functions. Infection and immunity 67:337-341. 
109. Parsonnet, J., H. Shmuely, and T. Haggerty. 1999. Fecal and oral shedding of 
Helicobacter pylori from healthy infected adults. Jama 282:2240-2245. 
110. Piccirillo, C. A., J. J. Letterio, A. M. Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, 
and E. M. Shevach. 2002. CD4(+)CD25(+) regulatory T cells can mediate suppressor 
function in the absence of transforming growth factor beta1 production and 
responsiveness. The Journal of experimental medicine 196:237-246. 
111. Price, A. B. 1991. The Sydney System: histological division. Journal of gastroenterology 
and hepatology 6:209-222. 
112. Qadri, F., A. Saha, T. Ahmed, A. Al Tarique, Y. A. Begum, and A. M. Svennerholm. 
2007. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in 
an urban community in Bangladesh. Infection and immunity 75:3961-3968. 
113. Qadri, F., C. Wenneras, M. J. Albert, J. Hossain, K. Mannoor, Y. A. Begum, G. Mohi, M. 
A. Salam, R. B. Sack, and A. M. Svennerholm. 1997. Comparison of immune responses 
in patients infected with Vibrio cholerae O139 and O1. Infection and immunity 65:3571-
3576. 
114. Quiding-Jarbrink, M., P. Sundstrom, A. Lundgren, M. Hansson, M. Backstrom, C. 
Johansson, K. Enarsson, M. Hermansson, E. Johnsson, and A. M. Svennerholm. 2009. 
Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. 
Clinical immunology 131:463-471. 
115. Raghavan, S., M. Fredriksson, A. M. Svennerholm, J. Holmgren, and E. Suri-Payer. 
2003. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation 
leading to increased pathology in Helicobacter pylori-infected mice. Clinical and 
experimental immunology 132:393-400. 
116. Raghavan, S., M. Hjulstrom, J. Holmgren, and A. M. Svennerholm. 2002. Protection 
against experimental Helicobacter pylori infection after immunization with inactivated H. 
pylori whole-cell vaccines. Infection and immunity 70:6383-6388. 
117. Rahman, M. M., D. Mahalanabis, S. A. Sarker, P. K. Bardhan, J. O. Alvarez, P. 
Hildebrand, C. Beglinger, and K. Gyr. 1998. Helicobacter pylori colonization in infants 
and young children is not necessarily associated with diarrhoea. Journal of tropical 
pediatrics 44:283-287. 
118. Rao, M. R., R. Abu-Elyazeed, S. J. Savarino, A. B. Naficy, T. F. Wierzba, I. Abdel-
Messih, H. Shaheen, R. W. Frenck, Jr., A. M. Svennerholm, and J. D. Clemens. 2003. 
High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural 
Egyptian infants and young children. Journal of clinical microbiology 41:4862-4864. 
119. Reshetnikov, O. V., D. V. Denisova, L. G. Zavyalova, V. M. Haiva, and C. Granberg. 
2003. Helicobacter pylori seropositivity among adolescents in Novosibirsk, Russia: 
prevalence and associated factors. Journal of pediatric gastroenterology and nutrition 
36:72-76. 
120. Robertson, M. S., J. F. Cade, H. F. Savoia, and R. L. Clancy. 2003. Helicobacter pylori 
infection in the Australian community: current prevalence and lack of association with 
ABO blood groups. Intern Med J 33:163-167. 
121. Rupnow, M. F., R. D. Shachter, D. K. Owens, and J. Parsonnet. 2000. A dynamic 
transmission model for predicting trends in Helicobacter pylori and associated diseases in 
the United States. Emerg Infect Dis 6:228-237. 
122. Sack, D. A., F. Qadri, and A. Svennerholm. 2008. Determinants of Responses to Oral 
Vaccines in Developing Countries. Annales Nestle 66:71-79. 
65 
 
123. Sawai, N., M. Kita, T. Kodama, T. Tanahashi, Y. Yamaoka, Y. Tagawa, Y. Iwakura, and 
J. Imanishi. 1999. Role of gamma interferon in Helicobacter pylori-induced gastric 
inflammatory responses in a mouse model. Infection and immunity 67:279-285. 
124. Shanks, A. M., and E. M. El-Omar. 2009. Helicobacter pylori infection, host genetics and 
gastric cancer. Journal of digestive diseases 10:157-164. 
125. Shevach, E. M., R. A. DiPaolo, J. Andersson, D. M. Zhao, G. L. Stephens, and A. M. 
Thornton. 2006. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T 
cells. Immunological reviews 212:60-73. 
126. Sjoling, A., G. Wiklund, S. J. Savarino, D. I. Cohen, and A. M. Svennerholm. 2007. 
Comparative analyses of phenotypic and genotypic methods for detection of 
enterotoxigenic Escherichia coli toxins and colonization factors. Journal of clinical 
microbiology 45:3295-3301. 
127. Smythies, L. E., K. B. Waites, J. R. Lindsey, P. R. Harris, P. Ghiara, and P. D. Smith. 
2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and 
exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol 165:1022-
1029. 
128. Sobala, G. M., J. E. Crabtree, M. F. Dixon, C. J. Schorah, J. D. Taylor, B. J. Rathbone, R. 
V. Heatley, and A. T. Axon. 1991. Acute Helicobacter pylori infection: clinical features, 
local and systemic immune response, gastric mucosal histology, and gastric juice 
ascorbic acid concentrations. Gut 32:1415-1418. 
129. Stingl, K., K. Altendorf, and E. P. Bakker. 2002. Acid survival of Helicobacter pylori: 
how does urease activity trigger cytoplasmic pH homeostasis? Trends in microbiology 
10:70-74. 
130. Storskrubb, T., P. Aro, J. Ronkainen, K. Wreiber, H. Nyhlin, E. Bolling-Sternevald, N. J. 
Talley, L. Engstrand, and L. Agreus. 2006. Antimicrobial susceptibility of Helicobacter 
pylori strains in a random adult Swedish population. Helicobacter 11:224-230. 
131. Stromberg, E., A. Lundgren, A. Edebo, S. Lundin, A. M. Svennerholm, and C. Lindholm. 
2003. Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum 
and duodenum. FEMS immunology and medical microbiology 36:159-168. 
132. Sutton, P., J. Wilson, T. Kosaka, I. Wolowczuk, and A. Lee. 2000. Therapeutic 
immunization against Helicobacter pylori infection in the absence of antibodies. 
Immunology and cell biology 78:28-30. 
133. Svennerholm, A. M., M. M. Levine, and J. Holmgren. 1984. Weak serum and intestinal 
antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients. 
Infection and immunity 45:792-794. 
134. Svennerholm, A. M., and A. Lundgren. 2007. Progress in vaccine development against 
Helicobacter pylori. FEMS immunology and medical microbiology 50:146-156. 
135. Terres, A. M., and J. M. Pajares. 1998. An increased number of follicles containing 
activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-
infected gastric mucosa. The American journal of gastroenterology 93:579-583. 
136. Thjodleifsson, B., H. Asbjornsdottir, R. B. Sigurjonsdottir, D. Gislason, I. Olafsson, E. 
Cook, T. Gislason, R. Jogi, and C. Janson. 2007. Seroprevalence of Helicobacter pylori 
and cagA antibodies in Iceland, Estonia and Sweden. Scandinavian journal of infectious 
diseases 39:683-689. 
137. Thomas, E., C. Jiang, D. S. Chi, C. Li, and D. A. Ferguson, Jr. 1997. The role of the oral 
cavity in Helicobacter pylori infection. The American journal of gastroenterology 
92:2148-2154. 
138. Thomas, J. E., S. Austin, A. Dale, P. McClean, M. Harding, W. A. Coward, and L. T. 
Weaver. 1993. Protection by human milk IgA against Helicobacter pylori infection in 
infancy. Lancet 342:121. 
66 
 
139. Thomas, J. E., A. Dale, M. Harding, W. A. Coward, T. J. Cole, and L. T. Weaver. 1999. 
Helicobacter pylori colonization in early life. Pediatric research 45:218-223. 
140. Tindberg, Y., C. Bengtsson, F. Granath, M. Blennow, O. Nyren, and M. Granstrom. 
2001. Helicobacter pylori infection in Swedish school children: lack of evidence of child-
to-child transmission outside the family. Gastroenterology 121:310-316. 
141. Tinnert, A., A. Hamlet, and A. M. Svennerholm. 1998. Antibodies against Helicobacter 
pylori in feces and saliva before and after eradication therapy. Clin Microbiol Infect 
4:634-643. 
142. Torres, J., M. Camorlinga-Ponce, G. Perez-Perez, L. Munoz, and O. Munoz. 2002. 
Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter 
pylori in infected children and adults in a country with high prevalence of infection. 
Clinical and diagnostic laboratory immunology 9:97-100. 
143. Uemura, N., S. Okamoto, S. Yamamoto, N. Matsumura, S. Yamaguchi, M. Yamakido, K. 
Taniyama, N. Sasaki, and R. J. Schlemper. 2001. Helicobacter pylori infection and the 
development of gastric cancer. The New England journal of medicine 345:784-789. 
144. Velin, D., L. Favre, E. Bernasconi, D. Bachmann, C. Pythoud, E. Saiji, H. Bouzourene, 
and P. Michetti. 2009. Interleukin-17 is a critical mediator of vaccine-induced reduction 
of Helicobacter infection in the mouse model. Gastroenterology 136:2237-2246 e2231. 
145. Viboud, G. I., M. J. Jouve, N. Binsztein, M. Vergara, M. Rivas, M. Quiroga, and A. M. 
Svennerholm. 1999. Prospective cohort study of enterotoxigenic Escherichia coli 
infections in Argentinean children. Journal of clinical microbiology 37:2829-2833. 
146. Walker, M. R., D. J. Kasprowicz, V. H. Gersuk, A. Benard, M. Van Landeghen, J. H. 
Buckner, and S. F. Ziegler. 2003. Induction of FoxP3 and acquisition of T regulatory 
activity by stimulated human CD4+CD25- T cells. The Journal of clinical investigation 
112:1437-1443. 
147. Weyermann, M., G. Adler, H. Brenner, and D. Rothenbacher. 2006. The mother as 
source of Helicobacter pylori infection. Epidemiology 17:332-334. 
148. Whitney, A. E., J. Guarner, L. Hutwagner, and B. D. Gold. 2000. Helicobacter pylori 
gastritis in children and adults: comparative histopathologic study. Ann Diagn Pathol 
4:279-285. 
149. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. 
Mattson, B. Basham, K. Smith, T. Chen, F. Morel, J. C. Lecron, R. A. Kastelein, D. J. 
Cua, T. K. McClanahan, E. P. Bowman, and R. de Waal Malefyt. 2007. Development, 
cytokine profile and function of human interleukin 17-producing helper T cells. Nature 
immunology 8:950-957. 
150. Wong, B. C., S. K. Lam, K. C. Lai, W. H. Hu, C. K. Ching, J. Ho, S. T. Yuen, C. K. 
Chan, G. K. Lau, and C. L. Lai. 1999. Triple therapy for Helicobacter pylori eradication 
is more effective than long-term maintenance antisecretory treatment in the prevention of 
recurrence of duodenal ulcer: a prospective long-term follow-up study. Alimentary 
pharmacology & therapeutics 13:303-309. 
151. Yamaoka, Y., T. Kodama, M. Kita, J. Imanishi, K. Kashima, and D. Y. Graham. 1999. 
Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 
8 production, and cagA status. Gut 45:804-811. 
152. Yang, X., H. Nishibayashi, T. Takeshita, and M. Kanehisa. 1999. Prevalence of 
Helicobacter pylori infection in Japan: Relation to educational levels and Hygienic 
conditions. Enviornmental Health and Preventive Medicine 4:202-206. 
153. Zhang, D. H., L. Y. Zhou, S. R. Lin, S. G. Ding, Y. H. Huang, F. Gu, L. Zhang, Y. Li, R. 
L. Cui, L. M. Meng, X. E. Yan, and J. Zhang. 2009. Recent changes in the prevalence of 
Helicobacter pylori infection among children and adults in high- or low-incidence 
regions of gastric cancer in China. Chinese medical journal 122:1759-1763. 
 
